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ABSTRACT
THE ROLE OF FYN AND B-CELL EXPRESSED ADAM10 IN EARLY B CELL
DEVELOPMENT, GERMINAL CENTER FORMATION AND TERMINAL B CELL
DIFFERENTIATION
By Natalia Sol Chaimowitz, Ph.D.
A dissertation submitted in partial fulfillment of the requirement for the degree of
Doctor of Philosophy of Virginia Commonwealth University
Virginia Commonwealth University, 2012
Director: Daniel H. Conrad, Professor, Department of Microbiology and
Immunology
In these studies we sought to determine the role of Fyn kinase and
ADAM10 in B cell biology. A disintegrin and metalloproteinase 10 (ADAM10) is a
zinc dependent proteinase related to matrix metalloproteinases. ADAM10 has
emerged as a key regulator of cellular processes by cleaving and shedding
extracellular domains of multiple transmembrane receptors and ligands. In
particular, ADAM10 has been identified as a key regulator of lymphocyte
development. Here we report that ADAM10 is dispensable for early B cell
development within the bone marrow. However, deletion of ADAM10 from all
peripheral B cells or in post-switch cells leads to severe impairments in humoral
responses. When ADAM10 was deleted from all peripheral B cells a decrease in
antigen specific IgG production was seen both with respect to serum levels and
IgG ASCs, indicating that plasma cell (PC) differentiation is influenced. Cells
producing high affinity antigen specific antibodies were particularly affected,
consistent with defects in germinal center (GC) reactions. Moreover, changes in

xviii

lymphoid architecture were also observed. Consistent with these findings,
follicular dendritic cell (FDC)-reticula was undetectable following immunization.
On the other hand, when ADAM10 was deleted in post-switch B cells, GC
formation and lymphoid architecture were not impaired. Despite normal
architecture, however, antibody production was still affected, likely due to
abnormal gene expression in ADAM10-deficient PCs. Consistent with this
hypothesis, PCs isolated from ADAM10Δ/ΔIgG1-cre+/- showed decreased
expression of genes that facilitate plasma cell differentiation and function and
increased expression of Bcl6, an inhibitor of PC differentiation.
Fyn kinase is a member of the Src protein tyrosine kinase. Fyn is widely
expressed in many cell types, including lymphocytes. Fyn has been shown to
interact with both the B cell and T cell receptor (BCR and TCR, respectively).
While Fyn-deletion did not impair the development of immature T cells and B
cells, TCR signaling was altered in mature T cells. Our results demonstrate that
Fyn-KO mice have significantly low basal levels of IgG1 and IgG2a. Additionally,
these mice displayed delayed kinetics in the production of NP-specific IgG1 and
IgG2b, and significantly low NP-specific IgG2a after a T-dependent immunization
protocol. Defects in antibody production correlated with significantly reduced
numbers of GC B cells, TFH cells and splenic PCs. Moreover, Fyn-KO B cells
showed decreased production antibody following in vitro activation. Our results
thus demonstrate that Fyn-mediated signaling and B cell ADAM10 expression
are necessary for optimal humoral responses.

xix

CHAPTER 1: INTRODUCTION TO B CELL DEVELOPMENT AND TERMINAL
DIFFERENTIATION

B-lymphocytes (B cells) are the key mediators of humoral immunity. There
are two main populations, referred to as B-1 and B-2 cells. B-1 cells are a minor
subpopulation of B cells commonly found in peritoneal and pleural cavities and
are mediators of innate immunity. B-2 B cells, on the other hand, are the
predominant B cell population and can be found in spleen and lymph nodes (LN).
Here we will discuss B-2 cells. B-1 B cell development and function is reviewed
elsewhere1.
B-2 cell development can be divided into several stages. The different
stages of B cell development are depicted in Figure 1 and will be further
described here.

1

Figure 1. B cell development and differentiation.
B cell development is initiated within the bone marrow (BM). Common lymphoid
progenitor cells (CLPs) commit to a B-cell pathway. Pro- and pre- B cells
undergo a series of steps in order to generate cells that express a functional
surface IgM. Once surface IgM is expressed, immature B cells exit the BM and
home to secondary lymphoid tissues, such as lymph nodes and spleen, where
they are considered mature B cells. Upon antigen activation, B cells proliferate
and differentiate. B cells can rapidly differentiate into PCs; these cells typically
secrete IgM and are short-lived. Activated B cells can also enter germinal
centers, where they undergo somatic hypermutation (SHM) and class switch
recombination (CSR). Cells that have low affinity for antigen undergo apoptosis,
while those B cells that express high affinity for antigen are selected for survival
and can further differentiate to memory B cells and PCs. Long-lived PCs typically
home to the bone marrow, where they can remain for years.

2
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1.1 Early B cell development
B cell development is initiated within primary lymphoid organs - the fetal
liver during gestation and the bone marrow (BM) throughout the remainder of life.
B cell development is carried out such that B cells with a diverse repertoire of
antigen specificities are generated. This diversity is achieved by rearrangement
of the immunoglobulin heavy-chain (IgH) and immunoglobulin light-chain (IgL)
segments of the B-cell receptor (BCR) genes. Moreover, recombination events
often lead to insertions or deletions in coding regions of immunoglobulin genes.
This junctional diversity also contributes to the generation of cells with very
varied

antigen

specificities.

encode enzymes essential

for

The recombination
the

rearrangement

activating
and

genes (RAGs)

recombination

of

immunoglobulin genes. These enzymes are known as RAG-1 and RAG-22.
These genes are also involved in T cell receptor (TCR) rearrangement, as
described elsewhere3. The importance of these enzymes is highlighted by the
fact that RAG-1 or RAG-2 deficiency causes severe combined immunodeficiency
(SCID) due to a loss/absence of B cells and T cells4.
Gene rearrangement starts with recombination of the variable (V),
diversity (D), and joining (J) gene segments of the IgH gene within pro-B cells,
commonly termed VDJ rearrangement. The pre-BCR is then assembled. It is
composed of the rearranged immunoglobulin M (IgM) heavy chain, a surrogate
light chain, composed of VpreB and λ5, and accompanying signaling molecules.
Productive IgM heavy-chain recombination leads to progression to the pre-B cell
stage. The pre-BCR is a key checkpoint for the regulation of B cell development,
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since pre-BCR expression and ligand-dependent signaling are prerequisites for
further differentiation. Defects in the components of the pre-BCR or signaling
molecules, such as Bruton’s tyrosine kinase (BTK), result in an early B cell
developmental block5.
CD19, a B cell specific member of the immunoglobulin superfamily, is a
co-receptor molecule that modulates pre-BCR and BCR signaling. CD19 is
expressed starting at the pro-B cell stage. It has been proposed that CD19
signaling is important for heavy-chain rearrangement by modulation of RAG-1
and/or RAG-2 expression6. Moreover, it has been suggested that CD19 signaling
can augment signals through the pre-BCR and aid in the transition from pro to
pre-B cell stage7. Consistent with this idea, CD19-deficient mice have impaired
B-cell proliferation at the pre-B cell stage8. Moreover, CD19 deficiency leads to
decreased numbers of peripheral B cells. CD19+/- mice (heterozygous), however,
had normal B cell development9.
Following heavy-chain rearrangement, rearrangement of the V and J
segments of the light chain locus (either κ or λ) occurs. This rearrangement
occurs at the pre-B cell stage. The light chain protein then associates with the
previously rearranged and synthesized IgM heavy chain. Surface IgM expression
marks the transition from pre-B cell to immature B cells. The immature, IgMexpressing B cell then leaves the BM and completes its maturation, becoming a
mature or naïve B cell, marked by the co-expression of IgM and IgD. Mature B
cells home to secondary lymphoid organs due to their expression of CX
chemokine receptor 5 (CXCR5) (see section 1.2)5.

5

1.2 Secondary Tissue Structure
The development of secondary lymphoid tissues is initiated during
embryogenesis by the interaction between hematopoietic lymphoid tissue inducer
cells (LTi) and mesenchymal cells present at the sight of future lymphoid organ
development. LTi cells express lymphotoxin αβ (LT) while mesenchymal cells
express LTβ receptor. LT signaling is essential for the development of secondary
lymphoid organs because it triggers mesenchymal cell differentiation to stromal
organizer cells and induces homeostatic chemokine expression, such as
CXCL13, CCL19, and CCL2110. Interaction of stromal organizer cells with LTi
leads to the recruitment of additional hematopoietic cells and subsequent
accumulation of naïve lymphocytes11.
Consistent with LT’s key role in lymphoid development, LT-deficient mice
lack peripheral LN and have severely disrupted splenic architecture12,13. TNF-α
deficient mice also have disrupted splenic architecture and abnormal lymph node
follicle formation14. However, TNF-α involvement in lymphoid tissue development
is poorly understood. It has been proposed that TNF-α is involved in the
differentiation of stromal cells precursors into follicular dendritic cells (FDCs) and
fibroblastic reticular cells (FRCs) (see section 3.3)15.
Secondary lymphoid organs are highly organized structure containing
regions enriched for B cells or T cells. The segregation of B cell areas (follicles),
and T cell areas (paracortex in lymph nodes and periarteriolar lymphoid sheath
(PALS) in spleen) is dependent on specific chemokine secretion16,17. The
6

chemokine important for B cell homing is CXCL13. This chemokine is thought to
be secreted by follicular dendritic cells (FDCs) within the follicles; its receptor,
CXCR5 is constitutively expressed by follicular B cells18. CCL19 and CCL21 are
secreted in T cell areas by fibroblastic reticular cells (FRC)19. Both of these
chemokines are ligands for CCR7, a receptor expressed by naïve T cells and
mature dendritic cells (DC) and are thus important for T cell homing and DC
migration into lymphoid tissues16,20,21 .
Along with B cell and T cell regions, spleens also have a marginal zone
(MZ), a structure that separates the lymphoid areas (white pulp) from the areas
where arterial to venous exchange occurs (red pulp). The MZ surrounds the
splenic follicles and it is made up of MZ macrophages and MZ B cells. MZ B cells
are characterized by high expression of CD21, IgM, and CD1, as well as low IgD
and CD23 expression22,23. Studies have demonstrated that MZ B cell
development requires CD19, Notch2, and ADAM10 protein expression and
signaling24-26.
Lymphocytes and DCs may enter LN from the blood by exiting the
circulation via high endothelial venules (HEV) in the paracortex or through
afferent lymphatics. Regardless of how they reach the tissue, B and T cells
segregate according to their expressed chemokine receptors27. As mentioned
earlier, the correct positioning of cells is dictated by the local production of
chemokines by stromal cells as well as the coordinated expression of chemokine
receptors by migrating cells18. The positioning of B cells and T cells, as well as
their migration during an immune response, are critical for adequate B cell-T cells
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interaction and for optimal immune responses28.

1.3 B cell activation
There are several ways B cells can encounter antigen. B cells can acquire
soluble antigen that diffuses freely into lymphoid follicles29 or that is transported
through the lymphoid conduits system15. Moreover, B cells can be presented
antigen by DC30 or subcapsular sinus macrophages27. B cells can respond to
several kinds of antigens31. After challenges with most types of antigens, B cells
rapidly differentiate into plasma cells (PCs) and plasmablasts and appear
between red and white pulp in the spleen and the outer T-cell areas of the lymph
nodes32. Extra-follicular responses are not thought to lead to the generation of
long-lived PCs32. It should be noted that extra-follicular responses to Tdependent antigens also require cognate T-cell help33.
T-cell independent antigens
Certain antigens have the capacity to induce the differentiation of B cells
into antibody-secreting cells (ASCs) in the absence of cognate T-cell help. These
antigens are commonly referred as T-independent antigens and can be
subdivided into two groups. Type-1 antigens can induce B cell proliferation and
differentiation to ASCs independently of BCR signaling. LPS is the prototypical
Type-1 antigen. Type 2 antigens, on the other hand, require signaling through
BCR and are typified by polysaccharides from bacterial cell walls. Common Type
2 antigens are haptens coupled to ficoll, dextran, or acrylamide. Type 2 antigens
lead to BCR aggregation; moreover, they may activate non-B cells to produce
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cytokines and modulate the immune response31.
All B cell subsets can be recruited to extra-follicular responses to Tindependent antigens, although MZ B cells and B-1b cells are the only ones
capable of responding to T-independent Type 2 antigens34. Low affinity IgM is the
most common isotype seen in T-independent responses, although other isotypes
can also be detected35. The process of class switching will be further described in
Section 1.4.

T-cell dependent antigens
Most antigens are T-dependent, meaning that T cell help is required for
optimal antibody responses. Helper T cells aid in the activation of cognate B cells
via cell-to-cell interactions (such as CD40 and CD40L) as well as through the
release of cytokines that shape the B cell responses, such as IL-4 and IL-21. A
hallmark of T-dependent antigens is that they are protein antigens. Like Tindependent antigens, they induce extra-follicular responses. Moreover, they also
induce germinal center (GC) formation (see Section 1.4)36,37.

1.4 Germinal Centers
GCs are structures observed in the follicular region of secondary lymphoid
tissues. As mentioned earlier, GC formation is dependent on the interactions of
cognate B cells and follicular helper T (TFH) cells and FDCs38. Within GCs, FDCs
and TFH cells promote antigen-specific clonal expansion, class switch
recombination (CSR) and somatic hypermutation (SHM) with selection of high
9

affinity BCR variants39. Clonal expansion refers to the rapid proliferation of
antigen-specific B cells.

Early responses to T-dependent antigens
Initial activation of naïve B cells through the BCR leads to increased
expression of CC-chemokine receptor 7 (CCR7) and enhanced responsiveness
to CD40L, thus promoting more effective cognate T cell help40. CCR7 expression
allows B cells to migrate toward the T cell zone. Simultaneously, CD4+ T cells,
activated by exposure to a peptide derived from the same antigen in the context
of MHC Class II, upregulate CXCR5 and migrate toward the B cell follicles41,42.
The original Th1/Th2 paradigm subdivides T cell immunity in into two
subsets specialized to regulate cell-mediate immunity (Th1) versus those that
mediate B cell antibody production (Th2)43. Th1 cells mediate immune responses
to intracellular pathogens through their secretion of IL-12 and IFN-γ44,45. On the
other hand, Th2 cells mediate responses to extracellular parasites through the
secretion of IL-4, IL-5, and IL-1343. Moreover, T cell help for antibody production
had been considered a property of Th2 cells46,47. Interestingly, mice deficient in
signal transduction and activator of transcription 6 (STAT6), a Th2 transcription
factor important for IL-4 signaling, were still capable of mounting T-cell
dependent antibody responses, although IgE was not produced48. These results
demonstrate that antibody responses can occur despite impaired Th2 responses.
More recently, several non-Th1, non-Th2 T cell subsets have been
identified. These subsets include T regulatory cells (Tregs), IL-17 secreting T cells
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(Th17), IL-9 secreting T cells (Th9), and follicular helper T cells (TFH)49-54 TFH
were first described as a unique CXCR5+ T cell population. CXCR5 expression
allows TFH cells to home to B cell follicular areas53,54. Moreover, TFH cells are
capable of providing B cell help for antibody production53,54.
The discovery of TFH cells raises several questions: (1) How do TFH cells fit
within the Th1/Th2 paradigm? (2) How do we explain all the previous data
implicating Th2 cells as helper cells for antibody production? A key question is
whether TFH represent a unique lineage or whether they represent a CXCR5+
subset of T helper cells suggesting plasticity in T cell subsets and the cytokine
mode. Moreover, even if they are a distinct lineage, there is a body of evidence
of T cell plasticity. Therefore, one could hypothesize that Th2 cells could become
TFH cells, and vice versa55-62.
Studies have demonstrated that TFH development requires antigenspecific priming by DCs involving ICOS-ICOSL interaction63-65. Moreover, full
commitment to a TFH phenotype requires B cell and T cell interaction63. The
expression of the adaptor molecule SAP (SLAM-associated protein) can regulate
B cell–TFH cell contact duration and is thus essential for TFH and GC
formation66,67. It has been proposed that IL-2 signaling, through STAT5, leads to
effector T cell differentiation, while low IL-2 signaling allows for Bcl6 expression6870

. Bcl6 commits T cells to a TFH phenotype while repressing Prdm1 gene

expression and preventing T cell effector differentiations

71

. In this context, TFH

cells are referred to as helpers, while other CD4+ T cell subsets are considered
effectors69,71,72.
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It has also been proposed that TFH cells are not a distinct helper T cell
subset and that TFH development occurs subsequent to Th1, Th2, Th17, and Treg
commitment60. In agreement with this model, it has been reported that TFH cells
differentiate from Th2 cells in response to helminth-derived antigens73. The main
issue with this model is that it would predict that TFH differentiation would not
antagonize other CD4+ T cell lineages. However, Bcl6, the main TFH transcription
factor, is capable of inhibiting other T cell differentiation pathways by blocking
Blimp-1 expression71,74-76.
The models proposed above, however, might not be mutually exclusive.
CD4+ T cells might differentiate into TFH cells directly, via DC priming and
interaction with cognate B cells. At the same time, other Th subsets (ex. Th2)
might be capable of differentiating into TFH cells. Although Bcl6 can inhibit the
differentiation of other Th subsets, it is not clear whether Bcl6 can inhibit the Th
program of already differentiated T cells. Moreover, if both these models were
correct, they would explain how Th2 cells were previously considered the key
providers of B cell help, as Th2 cells and TFH cells could represent that same
cellular subset.
Regardless of how they differentiate, it is well accepted that within the B-T
border B cells get help from cognate TFH cells60. The interaction between cognate
and T and B cells in the periphery of the B-cell follicle leads to the initiation of
proliferation. While some cells enter the follicle and form GCs, others continue to
proliferate and migrate toward the outer T-cell areas of lymph nodes or bridge
channels of the spleen white pulp and initiate extra-follicular responses41,77.
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Extra-follicular PC responses to T-dependent antigens seem to also require short
B cell and TFH interaction33,66. Recent evidence has also showed that early
memory B cells can develop in a GC-independent manner78,79.

Class switch recombination and somatic hypermutation
As previously mentioned, one of the events that occurs within GCs is class
switch recombination. Class switch recombination (CSR), also termed antibody
class switching, is an irreversible genetic recombination event that changes
antibody from one class to another, for example, from IgM to IgG. While CSR
does not change antigen specificity, it changes the function of the antibody, as
the constant region determines most antibody functions. Briefly, activationinduced cytidine deaminase (AID; also known as AICDA) deaminates cytosine
residues within the antibody switch (S) regions following germline transcription80.
Deamination then triggers the recruitment of the base excision repair (BER)
machinery, leading to uracil removal and single-strand breaks (SSBs)80. UNG,
an enzyme involved in the BER pathway, is particularly important for CSR.
Indeed, UNG deficient mice and patients with UNG mutations have a 95%
reduction in CSR81,82. If the SSBs are near each other on opposite DNA strands,
they destabilize the DNA, forming double stranded breaks (DSBs). However, if
they do not destabilize the DNA, they are repaired or converted to DSBs by
mismatch repair activity, another DNA repair pathway. DNA breaks then lead to
recombinations/translocations via non-homologous end joining (NHEJ)80.
Cytokines determine the isotype to which a B cell will switch through the
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induction of germline transcripts. While germline transcripts are sterile RNAs,
meaning that they do not encode proteins, they are thought to direct AID to a
specific S region. Germline promoters have cytokine-responsive elements,
therefore, they can be induced by cytokines80. It is in this way that different
cytokines drive commitment to different antibody classes. For example, IL-4
promotes IgG1 (IgG4 in human) and IgE class switching; interferon-γ (IFNγ)
induces IgG2a (in mice only); and transforming growth factor-β (TGFβ) leads to
IgA in both mice and humans40-42,80. While cytokines and innate stimuli alone can
drive B cell class switching, especially in vitro, typical responses require cognate
T cell help. Studies have demonstrated that antibody class switching can occur in
both GC and extra-follicular pathways80. Class switch recombination, however, is
likely to occur more efficiently within GCs given the cytokine milieu.
AID is not only required for CSR, but it also drives somatic
hypermutation83. Much like during CSR, AID is required for cytosine deamination
generating uracils and recruiting the somatic hypermutation machinery. These
changes target the variable regions of antibody genes. Uracil DNA glycosylate
(UNG) can then remove the uracil residues. DNA is subsequently processed by
error-prone DNA replication leading to the introduction of point mutations in the
actively transcribed immunoglobulin locus84. These mutations are likely to
change the binding of immunoglobulin to antigen, thus producing clones that with
increased or decreased affinity for antigen. Those clones that bind antigen with
high affinity will be selected. Therefore, it is said that somatic hypermutation
drives affinity maturation. While somatic hypermutation (SHM) occurs mostly
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within GCs, SHM has also been reported to occur outside of GCs as evidence by
the fact that some mice deficient in GCs exhibit affinity maturation with certain
types of immunizations85-88. DNA damage can trigger apoptosis. In order to allow
for rapid proliferation and SHM, GC B cells express anti-apoptotic proteins, such
as Bcl6 and myeloid cell leukemia sequence 1 (mcl-1)89,90.
As previously mentioned, AID is essential for SHM and CSR to occur.
Given that AID activity leads to mutations and changes in chromosomal
sequence, it is important for these mutations to be targeted to a specific area
instead of occurring throughout the genome. Studies have demonstrated that AID
preferentially deaminates the cytosine in WRC (W=A or T, R=purine), the AID
hotspot target. Variable and switch regions contain a large number of AID
hotspots80,91. However, it has been reported that AID is also able to deaminate
cytosines not present within hotspots. Moreover, not all hotspots are targeted80.
These findings demonstrate that there is another mechanism underlying AID
specificity that has yet to be described. Moreover, what prevents AID from being
expressed in cells other than B cells is poorly understood.

Affinity maturation
Studies have demonstrated that GC B cells continuously sample FDC
networks that are laden with immune complexes that form when several
antibodies bind soluble antigens. This B cell – FDC interaction is important for B
cell survival92-94. Following FDC scanning, a few GC B cells make stable contacts
with GC TFH cells94. While high affinity clones are selected within GCs, B cells
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expressing BCRs with low affinity for the antigen undergo apoptosis95. How B
cells with high affinity for antigen are selected is not fully understood. There are
currently two competing models describing selection of B cell expressing high
affinity BCRs: (1) BCR signal-based selection (classical model) and (2) BCR
signal and T cell help-based selection37.
In the classical model, B cells compete for antigen binding in the form of
immune complexes displayed on the surface of FDCs. GC B cell fate is
dependent on the degree of interactions with antigen. If BCR signaling is too
weak or too brief, the cell will undergo apoptosis – ‘death by neglect’96. Apoptotic
bodies are cleared by tingible body macrophages. FDCs are thought to control
the engulfment of apoptotic bodies97. If BCR signal is of sufficient strength, the
GC B cell will be selected. These selected cells could then present antigen to TFH
cells and this interaction could enhance GC B cell survival and/or stimulate the
differentiation into ASC or memory B cell37,96. In this model, GC B cell selection is
dependent on BCR signaling strength and the interaction between GC B cells
and FDCs. The small number of surviving cells would then interact with TFH cells
and further differentiate.
Another model has been recently proposed. This model suggests that B
cell- TFH interactions are important for selection of GC B cells expressing BCRs
with high affinity for the antigen. As in the classical model, GC B cells compete
for antigen binding on the surface FDCs. Those cells that receive an adequate
BCR signal survive, while those with inadequate BCR signal undergo apoptosis.
Contrary to the classical model, however, the T-cell based selection model
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argues that surviving GC B cells compete for T-cell help. Only those cells with
high affinity BCRs are capable of receiving enough T cell help to survive and
differentiate37. It has been proposed that the interaction between GC B cells and
TFH cells is the limiting factor in the selection of clones with high-affinity BCRs37.
It is, therefore, likely that both GC B cell – FDC and GC B cell – TFH interactions
are important for the selection of B cells expressing high affinity BCRs. Moreover,
recent studies have suggested that TFH cells and FDCs also interact, however,
whether these interaction occurs and its role in humoral responses has yet to be
determined98.

Other factors involved in GC formation and maintenance
There are many molecules that have been associated with GC formation.
Bcl6 expression, in both B cells and TFH cells, is required for GC development99101

. Bcl6 is a transcriptional repressor. Within GC B cells, Bcl6 is required to

prevent apoptosis in response to DNA damage that occurs during CSR and
SHM102. It has also been suggested that Bcl6 is required to halt plasma cell
differentiation until a cell has acquired sufficient affinity31. Studies have
demonstrated that IL-6 signaling can induce Bcl6 expression103,104. In the context
of a GC, IL-6 is produced by activated FDCs and promotes SHM and affinity
maturation105.
IL-21, the main cytokine produced by TFH cells, plays a key role in GC
formation and plasma cell differentiation78,106. Initially, mice deficient in either IL21 or IL-21R were reported to have profound defects in antigen-specific IgG
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production despite normal GC formation107. Detailed analysis demonstrated that
IL-21 deficient mice show decreased GC persistence78,106. Interestingly, normal
memory B cell were produced in IL-21 deficient mice106. STAT3, which acts
downstream of IL-21, as well as IL-6, IL-2, and IL-10, is essential for the
generation of IgG1 secreting cells108. IL-21, through STAT3 is able to trigger
Blimp-1 expression109,110, and could be involved in plasma cell (PC)
differentiation (see section 1.4).

Germinal Center Structure
Given the key role cell-cell interactions play in GC formation, affinity
maturation, and plasma cell differentiation, the organization of the GC is essential
for humoral responses. GCs have two zones, called the dark and light zone,
based on their initial histological appearance111. FDC, TFH and few GC B cells
occupy the light zone, while the dark zone is composed of closely packed GC B
cells. The chemokine receptor CXCR4 is required for GC B cell positioning within
the dark zone. Its ligand, CXCL12, is more abundant in this zone than in the light
zone37. CXCL13 is highly expressed within the light zone, where it accumulates
in the processes of FDCs17. CXCL13-mediated CXCR5 signaling seems to be
important for GC B cell positioning within the light zone. Previously, GC B cells
have been thought to move preferentially from the dark to the light zone.
However, recent studies have demonstrated GC B cells can also migrate from
dark zone to light zone. Moreover, B cells are also capable of intra-zonal
movement, for example, dark zone B cells can move within the dark zone93.
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It has been recently described that sphingosine-1-phosphate receptor 2
(S1P2) is required for GC B cells to stay within GC niche112. It has been proposed
that a gradient of sphingosine-1-phosphate (S1P), with highest concentrations
outside of GC and at the GC boundary, prevent GC B cell migration by mediating
S1P2-mediated inhibition of migration113.

Extra-follicular vs. GC pathway
Antigen-activated B cells that do not give rise to antibody-secreting cells in
an extra-follicular fashion can initiate GCs36,37. What commits a B cell to the
extra-follicular or GC-pathway is unclear, but it has been proposed that BCR
affinity for antigen, the amount of antigen-BCR interaction, and co-stimulatory
signals received from T cells might all play a role114-118. It has been proposed that
B cells with highest affinity differentiate into PCs in an extra-follicular manner,
while lower affinity B cells enter GCs where they mature and undergo affinity
maturation117. Whether FDCs play a role in the selection of the B cells that will
enter GCs is unknown.
Extra-follicular PC differentiation occurs early in an immune response. As
extra-follicular responses begin to decrease, long-lived PCs and memory B cells
begin to appear96. PCs of extra-follicular origin tend to be short-lived and are
non-migratory, while long-lived PCs reside in the BM where they secrete
antibody for several weeks or longer119,120. Interestingly, most long-lived PCs
show large numbers of somatic mutations, suggesting that they are GCderived39,96,121..
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immunoglobulin-secreting memory B cells. While PCs secrete large quantities of
antigen-specific antibodies, memory B cells undergo rapid proliferation and
differentiation to high affinity PCs upon secondary antigen encounter. It has been
suggested that the increased affinity of the BCR on memory cells leads to high
sensitivity to low-dose soluble antigens that do not induce primary responses.
Moreover, recent studies have suggested that memory B cells can re-initiate GC
reactions following antigen challenge122, although is unclear whether this
secondary GC is a re-expansion of a primary GC or a newly developed GC. This
is consistent with the concept of original antigenic sin. It describes that secondary
antigen exposures preferentially induce a memory response, while primary
responses are downregulated/inhibited123. The molecular changes involved in
memory B cell differentiation are not well characterized. Moreover, what
determines whether a GC B cell will become a PC or a memory B cell is not well
understood.

1.4 Plasma cell differentiation
One of the hallmarks of PC differentiation is a switch from transcription
factors that control mature B-cell gene expression programs, such as Pax5 and
Bcl6, to those that dictate PC program, such as B lymphocyte induced maturation
protein 1 (Blimp-1), XBP-1, and interferon regulatory factor 4 (irf4)31. While it is
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well established that these sets of transcription factors repress each other, it
remains unclear how B cells switch from a mature B cell program to a PC one.
Pax5 is a transcription factor that is expressed throughout the B cell
lineage and in all mature B cell subsets55. It is essential for both the
establishment and maintenance of B-cell identity. It can activate genes involved
in immunoglobulin gene rearrangement, BCR signaling, affinity maturation, and
SHM. Moreover, Pax5 represses the transcription of genes that are important for
PC development and function, such as Xbp-1124.
Blimp-1 triggers terminal B cell differentiation by repressing genes
required for GC reactions and inducing genes involved in Ig secretion76. It is,
therefore, important for Blimp-1 not to be expressed prematurely. Bcl6 has been
shown to repress prdm1, the gene encoding for Blimp-1, in both a direct and
indirect fashion68,70. Therefore, timely downregulation of Bcl6 is critical for PC
differentiation. Studies have demonstrated that BCR cross-linking induces Bcl6
phosphorylation and subsequent degradation125. This de-repression of Blimp-1,
as well as STAT3 activation via cytokines secreted by TFH cells, such as IL-21,
could lead to Blimp-1 expression109.
Blimp-1 is a transcriptional repressor often referred to as the “master
regulator” of PC differentiation. Studies have demonstrated that Blimp-1 is
sufficient to induce plasmacytic differentiation in vitro72. When Blimp-1-deficient
mice were immunized with either a T- dependent or T–independent antigen, the
number of Ig secreting cells and serum Ig levels were dramatically decreased
compared to control mice126,127. Moreover, deletion of Blimp-1 in mature PCs
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resulted in plasma cell apoptosis127. Blimp-1 represses mature and GC B-cell
genes, such as Pax5, Bcl6, and AID. Moreover, Blimp-1 leads to the expression
of genes important for plasma cell development and function, such as Ig genes
and XBP-1. Furthermore, Blimp-1 leads to the upregulation of CXCR4, a
chemokine receptor important for homing and maintenance of PCs in vivo75.
Interestingly, studies have demonstrated that Blimp-1 is not necessary to initiate
the process of plasma cell differentiation, as ‘pre-plasmablasts’ could be
generated in the absence of Blimp-176,128,129. Plasmablast are PC precursors that
express mature B cell makers, such as B220 and CD19, although to a lower
degree than naïve B cells130.
Irf4 is highly expressed in all PCs and it is essential for PC
differentiation131,132. While Irf4 is not required in B cells for GC formation, it
promotes isotype switching within GCs132. Irf4 is upregulated following B cell
activation. At low levels, it promotes AID expression and CSR and at higher
levels, it promotes Blimp-1 expression. Consequently, Irf4-deficient B cells fail to
induce Blimp-1131. It is likely that Irf4 plays a role in the initiation phase of PC
differentiation.
Blimp-1 and IRF4 lead to cell cycle arrest and promote PC development
133

. Moreover, they permit XPB-1 (X box binding protein-1) expression132,134.

XBP-1 is thought to be expressed following Blimp-1, since XBP-1 deficient B
cells express normal Blimp-1 levels following activation124,135. XBP-1 plays an
important role in mammalian unfolded protein response (UPR), a series of events
that allow for endoplasmic reticulum (ER) expansion and allow cells to handle
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extensive protein production136 as in the case of PCs. While the number of PCs
was normal in XBP-1 deficient mice, serum antibody levels were severely
impaired following antigen challenge. Phenotypically, however, these plasma
cells

showed

reduced

ER,

consistent

with

the

decrease

in

protein

production124,135. These results demonstrate that XBP-1 is not needed for plasma
cell development but is essential for antibody secretion.
The survival and differentiation of plasmablasts and PCs are dependent
on B-cell activation factor (BAFF) and a proliferation inducing ligand (APRIL),
members of the tumor necrosis factor (TNF) family137. Indeed, mice deficient in
BAFF, APRIL, or B cell maturation antigen (BCMA), one of the receptors for
these cytokines, demonstrated the key roles of these factors in the development
and maintenance of PCs, as PC numbers were severely impaired in these mice
compared to controls138-140. Studies have demonstrated that within the murine
bone marrow, eosinophils are the main source of these cytokines. Moreover,
they have demonstrated that eosinophils are essential for PC survival141.
Many of the mechanisms underlying B cell development, GC formation
and PC differentiation are still unknown. Here, we aimed to identify the role of
two distinct proteins, ADAM10 and Fyn, in B cell biology. ADAM10 is a
membrane of the family of disintegrin and metalloproteinases, and as such, it
mediates the cleavage of trasnmembrane proteins. Previous studies have
demonstrated a role for ADAM10 in B cell development24. We, therefore,
hypothesized that ADAM10 was involved in humoral responses. Here we
demonstrate that B cell expressed ADAM10 regulates lymphoid architecture, GC
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formation and PC development (See chapter 3). Fyn is a member of the Srcfamily kinase. Previous studies have implicated Fyn in antibody responses, but
the role of Fyn in GC formation had yet to be determined142,143. Here we
demonstrate that Fyn is required for optimal GC formation. Fyn-deficient mice
show impaired antibody responses. Moreover, Fyn-deficient B cells produce less
antibodies than their wild type counterparts when activated in vitro, suggesting a
B-cell intrinsic defect (See chapter 4).
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CHAPTER 2: MATERIAL AND METHODS

2.1 Mice
ADAM10B-/- mice were previously described24. To generate ADAM10B-/N2ICD-TgB+, ADAM10B-/- mice were mated with N2ICD-Tgflox/flox mice144. CD19cre- mice were wild type littermates of ADAM10B-/- and ADAM10B-/-N2ICD-TgB+
mice. CD23Tg mice have been previously described145. Balb/CJ mice were used
as littermate controls of CD23Tg mice. Fyn-KO mice were previously described,
and B6.129 mice were used as WT controls146. In order to generate
ADAM10Δ/ΔIgG1-cre+/-YFP+ mice, ADAM10Δ/ΔYFP+ mice were mated with IgG1cre+/-128 mice that were purchased from Jackson mice. ADAM10+/+IgG1-cre+/YFP+ mice were used as controls. To generate ADAM10Δ/Δ mb1-cre+/-YFP+ mice,
ADAM10Δ/ΔYFP+ mice were mated with mb1-cre+ mice, kindly provided by
Michael Reth through the laboratory of David Allman147. CX3CR1-deficient mice
were purchased from Jackson Laboratory148. All mouse protocols were approved
by the Virginia Commonwealth University Institutional Animal Care and Use
Committee.

2.2 PCR and Quantitative PCR
PCR
For genotyping, DNA was isolated using Direct PCR Solution as directed
by the manufacturer (Viagen). MangoMix (Bioline) was used for amplification of
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mb1, IgG1, and CD19 cre-lines, ADAM10-floxxed alleles, and YFP and N2ICD
transgenes. Cycling conditions were as follows, 95°C for 3 min, 35 cycles of 94°C
for 1 min, 55°C for 1 min, 72°C for 2 min, and final extension at 72°C for 10 min.
Sequences of all primers described above are listed in Table 1.

Quantitative PCR
Total RNA was extracted and purified from draining and non-draining
mouse lymph nodes (LNs) using TRIzol reagent (Invitrogen). Samples were
treated with DNase (Takara Bio), mixed with phenol/chloroform/isoamyl alcohol
solution (25:24:1; USB), and precipitated with ethyl alcohol. The purity of RNA
was quantified by a spectrophotometer (ND-100; NanoDrop). One microgram of
RNA was reverse transcribed using the High Capacity cDNA RT kit (Applied
Biosystems). Real-time quantitative PCR was performed with a real-time PCR
machine (iQ5; Bio-Rad Laboratories). Primers and probes for running a TaqMan
quantitative PCR assay were purchased from Applied Biosystems. TaqMan gene
expression

assays

used

included:

CCL19:

Mm00839967_g1,

IL-21:

Mm00517640_m1, Aidca: Mm01184115_m1; Xbp1: Mm00457357_m1, Prdm1:
Mm00476128_m1, Bcl6: Mm00477633_m1; and Irf4: Mm00516431_m1. Primers
for CCL21 were synthesized by IDT as previously described149. PCR products,
labeled with 6-FAM–conjugated probes, were amplified with 18S as an internal
control. Reaction parameters were as follows: hold at 48 ̊C for 30 min and hold at
95 ̊C for 10 min, followed by 40 cycles of 95 ̊C for 15 s and 60 ̊C for 60s. Results
were analyzed with iQ5 real-time PCR software (version 2.0). Sequences of all
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primers and probes, except those included in purchased Taqman gene
expression assays described above, are listed in Table 1.
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Table 1. Primer and probe sequences.
S- sense, AS- anti-sense
PCR

5’3’

ADAM10: Intron8

CAGTGTAAATGTGAACTCACCC

ADAM10: Intron9

CGTATCTCAAAACTACCCTCCC

N2ICD: N2AD1

CCTTATGATGTTCCCGATTATGC

N2ICD: N2AD2

AGTACACCCATCTGGGCCTCG

YFP:oIMR4982

AAGACCGCGAAGAGTTTGTC

YFP: oIMR8545

AAAGTCGCTCTGAGTTGTTAT

YFP: oIMR8546

GGAGCGGGAGAAATGGATATG

CD19-cre: oIMR1084

GCGGTCTGGCAGTAAAAACTATC

CD19-cre: oIMR1085

GTGAAACAGCATTGCTGTCACTT

IgG1-cre: 9264

TGTTGGGACAAACGAGCAATC

IgG1-cre: 9265

GTCATGGCAATGCCAAGGTCGCTAG

IgG1-cre: 9266

GGTGGCTGGACCAATGTAAATA

Mb1-cre: hCre dir

CCCTGTGGATGCCACCTC

Mb1-cre: hCre rev

GTCCTGGCATCTGTCAGAG

Quantitative PCR
18S S

AAAATTAGAGTGTTCAAAGCAGGC

18S probe

CGAGCCGCCTGGATACCGCAGC

18S AS

CCTCAGTTCCGAAAACCAACAA

CCL21 S

AGACTCAGGAGCCCAAAGCA

CCL21 AS

GTTGAAGCAGGGCAAGGGT

CCL21 probe

CCACCTCATGCTGGCCTCCGT
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2.3 Immunization.
For all immunization protocols, mice were of 6-12 weeks of age, unless
otherwise stated. When experiments were terminated, mice were sacrificed via
isofluorane inhalation and cervical dislocation. All mouse protocols were
approved by the Virginia Commonwealth University Institutional Animal Care and
Use Committee.

T-dependent immunizations.
For T-dependent immunization protocol, mice were immunized with a
single 10 µg 4-Hydroxy-3-nitrophenylacetyl injection coupled to keyhole limpet
hemocyanin at a ratio of 27:1 (NP27KLH – from this point called NPKLH)(Biosearch Technologies). For memory protocols, mice were then given a
second immunization of 10 µg of NP-KLH 42-49 days after primary immunization.
For i.p. injections, mice were given 200µL of immunization mixture, made as
follows: 10µg of NP-KLH in 100µL of PBS and 100µL of alum (4mg). For footpad
injections, mice were given 25µL of immunization mixture, made as follows: 10µg
of NP-KLH in 10µL of PBS and 15µL of alum (0.6mg). Mice were bled weekly via
tail vein nick and cardiac punctured when the experiment was terminated.
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T-independent immunizations.
Mice were immunized with 100 µg of NP0.6LPS (Biosearch Technologies)
i.p. in 100µL of PBS. Mice were bled weekly via tail vein nick and cardiac
punctured when the experiment was terminated.

Immune Complexes.
Mice were passively immunized subcutaneously (s.c.) in the nape of the
neck with 6mg of rabbit polyclonal anti-OVA antibodies in 400µL of PBS
(Meridian Life Sciences). Twelve hours later, mice were immunized with 100µg
NP24OVA s.c. in alum. Immunization mixture consisted of 100µg of NP24OVA in
PBS and 100µL of alum (4mg). Six days following immunization mice were
sacrificed and cardiac punctured.

The different NP-conjugates used are summarized in Table 2.
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Table 2. NP-conjugated antigens
Antigen

Use

NP27KLH

T-dependent immunization

NP4BSA

High affinity NP-specific ELISA/ELISPOT

NP14BSA

Total NP-specific ELISA/ELISPOT

NP0.6LPS

T-independent Immunization

NP24OVA

Immune complexes studies
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2.4 Cell isolation
Tissue Preparation
Single cell suspensions of peripheral lymph node (LN) cells and
splenocytes were generated by disrupting tissue between glass slides. BM cells
were isolated by flushing excised tibias and femurs with complete RPMI. Red
blood cells were then lysed by using ACK lysis buffer. Cells were then plated or
stained depending on the experimental design.

B cell and Plasma Cell isolation
Cellular isolations were carried out using magnetic bead (Miltenyi Biotec).
Briefly, single cell suspension was generated as previously described (see tissue
preparation). Cells were resuspended in MACS buffer (PBS pH 7.2, 0.5% BSA
and 2mM EDTA) and incubated with the corresponding magnetic beads for 15
minutes at 4°C. Cells were then washed and passed through a magnetic column.
When cells were isolated via negative selection, LD columns were used and flowthrough was harvested. On the other hand, when cells were isolated via positive
selection, LS columns were used. In this case, after cells were passed through
the column, columns were washed and flushed with MACS buffer and the eluted
cells were utilized for experiments. When a small number of cells were isolated
via positive selection, MS columns were used. For B cell isolation, cells were
isolated via positive selection (B220+ cells) for all cells or via negative selection
(CD43-) for isolation of naïve or untouched B cells. PCs were isolated via
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negative selection (B220-DX5- cells) and subsequent positive selection (CD138+
cells).

Stromal Cell Isolation
In order to isolate LN stromal cells, lymph nodes were processed by
enzymatic digestions. Protocol was carried out as previously described, with
minor modifications150 LN were isolated, cut in small pieces with micro-scissors
and place in RPMI-1640 on ice. After all LN were dissected, media was removed
and replaced with 2mL of freshly made enzyme mix. Enzyme mix consists of
0.8mg/mL Dispase (Roche), 0.8mg/mL collagenase IV (Invitrogen) and
0.1mg/mL DNase I (Invitrogen) in RPMI-1640. Cells were incubated at 37°C in a
water bath for 20 minutes; gently inverting at 5 minute intervals to ensure the
content were well mixed. The LN were then gently aspirated and expirated to
disrupt the capsule. Large fragments were allowed to settle and the enzyme mix
was then removed and added to 10mL of ice-cold FACS buffer (PBS with 2%
FBS). 2mL of fresh enzyme mix was added to the digestions tube and gently
mixed. Tubes were then incubated for 10 min at 37°C. Cells were then mixed
vigorously for 30 seconds. As previously, large fragments were allowed to settle
and enzyme mixed was removed and transferred to the tube containing 10mL of
ice-cold FACS buffer. 2mL of fresh enzyme mix was then added to digestions
tube. Tube was incubated at 37°C and mixed vigorously every 5 minutes until all
lymph node fragments were completely digested. All supernatants were then
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combined and spun down 1200 RPM for 5 minutes. Cells were then analyzed via
flow cytometry (see section 2.6).

2.5 Enzyme Linked Immunosorbant Assay (ELISA) and Enzyme Linked
Immunosorbant Spot (ELISPOT)
Total antibody levels.
For total Ig ELISAs, ELISA plates were coated with 5 µg/mL of goat-anti Ig
(Southern Biotech) in BBS (0.15 M sodium chloride, 0.01 M borate buffer,
pH=8.5). Plates were then incubated at 37°C for an hour or at 4°C overnight.
Plates were then washed three times with ELISA wash (PBS with 0.02% Tween20). Blocking solution (PBS with 0.02% Tween-20 and 2% FBS) was added to
plates. Plates were then incubated at 37°C for an hour or at 4°C overnight. Plates
were then washed three times with ELISA wash and samples were added,
diluted in block. For standard curve, normal mouse Ig (Southern Biotech) was
used. Plates were then incubated at 37°C for an hour or at 4°C overnight. Plates
were then washed three times with ELISA wash and goat-anti-Ig-alkaline
phosphatase (AP) was added to plates. Goat-anti-Ig-AP was diluted in block
(1:400 dilution) (Southern Biotech). After 1 hour incubation at 37°C, plates were
washed and developed with phosphate tablets (sigma) dissolved in substrate
buffer (0.1g MgCl2.6H20, 0.2g NaN3, 50mL diethanolamine, pH to 9.8 per
500mL). Absorbance at 405nm was measured.
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NP-specific ELISA.
For NP-specific ELISAs, ELISA was carried out as previously described with
minor

modification.

Plates

were

coated

with

NP14BSA

(Biosearch

Technologies)(15 µg/mL in PBS) for samples and with 5 µg/mL of goat-anti Ig
(Southern Biotech) in BBS for standard. The remaining steps were carried out as
previously described (see total antibody levels). For measurement of high affinity
antibodies, protocol was carried out as described except that plates were coated
with NP4BSA (Biosearch Technologies; 15 µg/mL). While only high affinity
antibodies can efficiently bind NP4BSA, both low and high affinity antibodies bind
NP14BSA. The described NP-specific ELISA protocol allows for the relative
quantification of high vs. low affinity antibodies151.

TNF-α ELISA
TNF-α levels were measured by ELISA using a TNF-α ELISA assay kit
(Peprotech) and following manufacturer’s instructions.

ELISPOT.
For ELISPOT, 96-well MultiScreen filtration plates (Millipore) were coated
with 15 µg/mL of NP4BSA or NP14BSA in PBS. Plates were then incubated at 4°C
overnight. Plates were then washed with PBS three times and complete RPMI
was added to the plates. Plates were then incubated with media for at least 3
hours at 37°C. Meanwhile, splenic, LN, and BM cells were made into a single cell
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suspension, as previously described (see section 2.4). Cells were seeded into
the plate in duplicate, with at least three serial dilutions, and cultured for 18 hours
at 37 °C in 100µL of complete RPMI. Plates were developed as previously
described152. Briefly, following incubation, plates were washed three times with
0.02% Tween-20 in PBS and incubated for 2 hours at 37°C with biotinylated antiIg (1:1000 dilution in PBS) (Southern Biotech). During the incubation, APC
solution was prepared following manufacturer instructions (VECTASTAIN Elite
ABC system, Vector Laboratories). APC solution was incubated for at least 30
minutes prior to addition to ELISPOT plates. Following incubation, plates were
then washed as before. Plates were then incubated with APC solution for 1 hour
at room temperature. During the incubation, AEC Solution was prepared. AEC
solution consists of one 3-Amino-9-ethylcarbazol (AEC) tablet dissolved in 2.5mL
of dimethylformamide (DMF). After tablet dissolved, 47.5mL of acetate buffer
(0.1N acetic acid and 0.1M sodium acetate) and 25µL of H2O2 were added.
Following incubation with APC solution, plates were washed and AEC solution
was added. Following a 4-minute incubation at room temperature, the reaction
was stopped by rinsing the plates with water. Plates were then allowed to dry
overnight, and spots were counted under dissecting a microscope. It should be
noted that the number of cells plated and time of incubation were optimized.
These parameters are affected by immunization protocol and immunoglobulin
isotype of interest. Generally, total antigen-specific IgG and IgM are readily
detected when cells are incubated for 18 hours at concentration of 0.5x106
cells/well, 21 days post-immunization.
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2.6 Flow cytometry, immunofluorescence and confocal microscopy.
Flow cytometry
Cell isolation was conducted as described previously (see section 2.4 Cell
Isolation). Cells were labeled following RBC lysis and filtration through 40µm cell
strainers. For surface staining, cells were washed in FACS buffer (2% FBS in
PBS). 1-3x106 cells were re-suspended in 50-100µL. Cells were then incubated
on ice with 1-5µg of Fc block (2.4G2) for 10 minutes to prevent non-specific
staining. Subsequently, cells were incubated for 30 min on ice with different
combinations of 0.25-0.5µg of anti–mouse antibodies. Cells were then washed
with FACS buffer and analyzed. For intracellular staining, staining was carried
out using PhosphoFlow kit (BD). Briefly, cells were stained extracellularly as
described. Cells were then washed with FACS buffer and fixed by the addition of
2mL of pre-warmed Lyse/Fix buffer (1X) and incubation at 37° C for 10 minutes.
Cells were then washed with FACS buffer and permealized with 1mL of
Perm/Wash buffer for 15-30 minutes at room temperature. Following
permealization, cells were washed and resuspended in 50-100µL of Perm/Wash
buffer. Cells were incubated with 1-5µg of Fc block (2.4G2) in Perm/Wash buffer
for 5 minutes at room temperature. Subsequently, cells were incubated for 45
minutes with anti-mouse antibodies. Cells were then washed with Perm/Wash
buffer, resuspended in FACS buffer, and analyzed. Flow cytometry analysis was
performed using a Canto or AriaII (BD Biosciences) using Diva at the Flow
Cytometry Core at Virginia Commonwealth University. Expert technical
37

assistance by Julie Farnsworth is acknowledged. Flow cytometry data analysis
was conducted with FlowJo v8.8.7 (Tree Star).

Immunofluorescence and confocal microscopy.
Spleen and LN were frozen on dry ice in OCT compound (Tissue-Tek;
Sakura). Serial 10µm sections were cut from frozen blocks using a cryostat
(Frigocut 2800E; Jung), fixed in absolute acetone, and air-dried. Sections were
blocked with 10% BSA in PBS to prevent background staining and then washed
and incubated for 60 min with different combinations of 2-5 µg/ml anti–mouse
antibodies. Sections were washed, mounted with anti-fade mounting medium
(Vectashield; Vector Laboratories), cover slipped, and examined with a confocal
laser scanning microscope (TCS-SP2 AOBS; Leica) fitted with an oil PlanApochromat 40× objective. Two lasers were used: argon (488 nm) for FITC, and
HeNe (543 nm) for PE and APC. Parameters were adjusted to scan at a 512 ×
512 pixel density and an 8-bit pixel depth. Emissions were recorded in three
separate channels. Digital images were captured, overlaid, and processed with
the Confocal and LCS Lite programs (Leica).

Antibodies.
All antibodies are anti-mouse, unless otherwise noted.
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Table 3. Flow cytometry and Immunohistochemistry antibodies
Specificity

Clone

ADAM10
B220/CD45R

RA3-6B2

Label

Source

PE, FITC

R&D

FITC, PE, APC, PE-Cy7, Biolegend
Alexa 674, Alexa 700,
PerCP/Cy5.5

BCL6*

K112-91

CCL21

PE

BD Bioscience

Unlabeled

R&D

CD16/32

2.4G2

Unlabeled

Conrad Lab

CD19

6D5

PE, APC, PerCP/Cy5.5

Biolegend

CD21/CD35

7G6

PE

Biolegend

CD31

MEC13.3

APC

Biolegend

CD38

90

PE-Cy7

Biolegend

CD4

RM4-5

APC

Biolegend

CD4

H129.19

PE

Biolegend

CD43

1B11

PE-Cy7

Biolegend

CD45

30-F11

FITC

Biolegend

CXCR5

RF8B2

Biotin

BD Biosciences

Fas (CD95)

Jo2

PE

BD Bioscience

FITC, APC

eBioscience,

GL7

(B

and

T GL7

activation marker)

BD

Bioscience

gp38 (podoplanin)

8.1.1

PE

Biolegend

IgD

11-26c.2a

PE, PerCP/Cy5.5

BD Biosciences

IgG1

A85-1

APC, PE

BD Bioscience

IgM

RMM-1

PE,

APC,

APC-Cy7, Biolegend

PerCP/Cy5.5
Thy1.2

30-H12

FITC

Southern Biotech

*Anti-human, cross-reactivity with mouse Bcl6.
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2.7 In vitro activation
In vitro activation of antibody production
For IgG1 and IgE production, B cells or splenocytes were cultured with CD40Ltransfected Chinese hamster ovary (CHO) cells as a B cell stimulant (6x104
cells/well) or with 1µg/mL of stimulating anti-CD40 antibody (Invitrogen) and IL-4
(10,000U/mL) for seven days. Supernatants were then harvested and analyzed
for IgG1 and IgE production by ELISA. Cells were also stimulated with 50µg/mL
of LPS (sigma). Four days later, supernatants were harvested and analyzed for
IgM and IgG3 production.
Proliferation
To determine proliferation, cells were isolated and stimulated as described (see
above). After 96 hours in culture, cells were pulsed with 1 µCi/well of tridiated
([3H])-thymidine (Perkin Elmer) for 24 hrs. Plates were then harvested onto GFC
plates using a filtermate cell harvester. Plates were dried for at least 2 hours,
25µL of scintillation fluid was added, and counts were determined using the
Topcount Plate Counter (Perkin Elmer, Waltham, MA). Proliferation was reported
as counts per minute (CPM).

2.8 Migration Assay
For B cell migration studies, spleens were harvested and made into a single cell
suspension, as previously described in section 2.4. Cells were washed in
migration media (RPMI containing 0.5% fatty acid free BSA and 10mM HEPES)
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and then incubated in this medium for 30 minutes at 37°C prior to the assay.
Migration assay was performed using 5µm transwell (Corning Costar Corp.).
Briefly, 600µl of media containing 1µg/mL of CXCL13 (Peprotech), 300ng/mL of
CXCL12 (Peprotech), or just media was added to the lower chamber. After
insertion of the filter, 1x106 cells were added to the top chamber in 100µL. After 3
hours at 37°C, cells in the lower chamber were analyzed by flow cytometry. Cells
were stained and resuspended in 60µL of FACS buffer. Events were collected at
a high flow rate for 60 seconds. For the calculations of specific migration, a
known number of cells were added to the bottom chamber. Chemotaxis is
expressed as percent of input cells.

2.9 Statistical analysis.
When dealing with two groups, p-values were calculated using unpaired twotailed Student’s t-tests in Graphpad Prism, unless samples did not form a
Gaussian distribution, indicated by a failed D’Agostino and Pearson omnibus
normality test. In the case of non-parametric populations, p-values were
calculated using two-tailed Mann-Whitney test. When more than two were
compared, p-values were calculated using a one-way analysis of variance with a
Tukey post-test. Error bars represent the standard error of the mean (SEM)
between samples. p<0.05 is considered significant.
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CHAPTER 3: ADAM10 AND ITS ROLE IN EARLY B CELL DEVELOPMENT,
GERMINAL CENTER FORMATION AND PLASMA CELL FUNCTION

3.1 Introduction to ADAM10
ADAM10 is a member of a family of disintegrin and metalloproteinases.
(ADAMs). ADAMs belong to the metzincin superfamily, along with matrix
metalloproteinases (MMPs) and ADAM-thromospondins (ADAM-TS). While all
functionally active metzincin proteases contain a zinc binding motif, ADAMs are
unique in that they also contain a transmembrane domain and are active while
membrane bound. ADAMs are therefore responsible for the processing of
receptors and ligands expressed on the cell surface. ADAMs can mediate
ectodomain shedding and regulated intramembrane proteolysis (RIP) of
transmembrane proteins. Shedding of extracellular domains releases soluble
fragments into the extracellular space. This cleavage event can lead to
downregulation of events that depend on transmembrane receptor-ligand
expression or can activate paracrine and/or autocrine signaling by the production
of a soluble mediator, such as necrosis factor-α (TNF-α). While ectodomain
shedding is thought to occur constitutively, RIP requires receptor-ligand
interaction153.

The

prototypical

ADAM

is

composed

of

a

prodomain,

metalloprotease domain, a disintegrin domain that confers substrate specificity, a
cysteine-rich region, a transmembrane domain, and a cytoplasmic tail87,154. A
prototypical ADAM is depicted in Figure 2.
Ever since ADAM10 and its Drosophila homolog, Kuzbanian (kuz), were
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discovered, their key role in developmental pathways has been noted. Kuz was
initially identified in 1996. Studies of kuz-deficient embryos revealed that kuz was
required for the development of peripheral and central nervous system. Cloning
analysis demonstrated that the kuz gene encodes for a metalloproteasedisintegrin, highly homologous to bovine metalloprotease, later named
ADAM1080,155,156. Subsequent studies demonstrated that nervous system defects
were due to defective Notch receptor signaling in the absence of kuz mediated
RIP157. The importance of ADAM10 for mammalian development has also been
demonstrated, likely due to the key role of ADAM10 in the initiation of Notch
signaling. Murine studies revealed that ADAM10-deficient embryo die very early
in development, embryonic day 9.5, with multiple defects of the developing
center nervous system and cardiovascular system84,158
ADAM10 has emerged as a key mediator of ectodomain shedding and
RIP of a large number of substrates, such as Notch receptors, CD23, and TNF-α,
(more ADAM10 substrates are discussed in Table 4)87,153. While it is well
accepted that ADAM10 mediates cleavage of membrane-bound substrates,
recent evidence demonstrates that ADAM10 activity is not restricted to the
plasma membrane. Indeed, several reports have demonstrated that ADAM10
and a few of its substrates are present in exosomes, which are small secreted
vesicles159,160. Moreover, it has been reported that ADAM10 is highly expressed
in the endoplasmic reticulum (ER)161. Whether the ER represents a reservoir for
ADAM10 or if ADAM10 is functional within this organelle has yet to be
determined. Furthermore, it has been recently demonstrated that the intracellular
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domain of ADAM10 can be processed by ADAM9, ADAM15 and γ-secretase,
allowing for the ADAM10 intracellular domain (ICD) to translocate to the nucleus
and modulate gene expression162. Recently, it has been demonstrated that
ADAM10-ICD is involved in human prostate cancer progression and in human
immunodeficiency virus Type-1 replication163,164.
Despite ADAM10’s key role in development, relatively little is known
regarding its regulation. ADAM10 is expressed as a zymogen and is
subsequently activated by cleavage of the pro-domain by a furin protease100,165,.
Following activation, ADAM10 activity can be regulated in a variety of ways.
Tissue inhibitors of metalloproteases (TIMP), including TIMP1 and TIMP3, have
been demonstrated to inhibit ADAM10 activity in vitro166,167. Several studies have
demonstrated that ADAM10 proteolytic activity can be enhanced by calcium
influx, retinoic acid receptor signaling, PKC signaling, cholesterol depletion, and
N-glycosylation168-172.
Some of the most well characterized ADAM10 substrates are Notch
receptors. As mentioned earlier, Notch receptors regulate cellular differentiation.
Following Notch receptor-ligand interaction, including Delta-like 1-4 and Jagged
1-2, Notch signaling is initiated by ADAM-mediated proteolysis of the
extracellular domain of the Notch receptor. The extracellular domain is released
and endocytosed by adjacent ligand-expressing cells. This cleavage event,
termed S2 cleavage, produces a substrate that can then be cleaved by the γsecretase complex (S3 cleavage). Subsequently, the Notch intracellular domain
(NICD) is released from the cell membrane. NICD then translocates to the
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nucleus where it complexes with the transcription factor RBP-Jκ and induces the
transcription of Notch target genes, such as CD21, Hes 1, Hes 5 and deltex-1173.
Notch1 and Notch2 are the main Notch receptors involved in lymphocyte biology.
It has been demonstrated that ADAM10 can mediate their cleavage24,174. Notch1
and Notch2 have been shown to mediate different functions. For example, while
Notch1 is required for T cell development, Notch2 signaling is necessary for the
development of marginal zone B cells25,174. These cleavage events are depicted
in Figure 2B. Recent studies have demonstrated that ADAM10 can also mediate
trans-cleavage, however, these activity has only been demonstrated for one
substrate, ephrin, and it is not thought to be ADAM10’s main mechanism of
action175.
Studies have demonstrated that Notch1 signaling is essential for
commitment to T cell lineage, and given its role in Notch1 signaling, ADAM10
also plays a key role in T cell development174,176. Moreover, ADAM10 is essential
for MZ B cell development due to its role in the initiation of Notch2 signaling24,25.
Notch signaling has been recently implicated in mature B cell activation and
function. Thomas et al. demonstrated that Notch signaling synergizes with B-cell
receptor (BCR) and CD40 signaling to enhance B cell activation177. Further
studies by Santos et al. showed that Notch signaling contributes to B cell
differentiation into antibody secreting cells (ASC) in vitro and also, under some
conditions, promotes class switching178 In addition to B-cell activation and
differentiation into ASCs, Notch signaling has also been implicated in GC
formation. Yoon et al. recently demonstrated that Notch signaling protects GC B
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cells from apoptosis. These reports demonstrate the importance of Notch
signaling in regulating B cell survival, activation, and differentiation into ASCs179.
These studies failed to determine whether the results observed were due to
Notch1 or Notch2 activation. Moreover, these results were obtained through in
vitro studies that might not represent in vivo biology. Interestingly, B-cell specific
RBP-Jκ deficient mice showed no defect in T-dependent or T-independent
antibody responses180, thus suggesting that Notch signaling might affect B cell
terminal differentiation in a RBP-Jκ independent-manner, RBP-Jκ deficiency can
be compensated in vivo or Notch signaling might not be important in vivo.
Here we aimed to address the role of ADAM10 in early B cell
development, in GC formation, and PC development and function. We
conditionally deleted ADAM10 in B cells at three distinct developmental stages
and assessed the impact in B cell development and function in each of the
mouse lines. Our results demonstrate that early deletion of ADAM10, starting at
the pro/pre-B cell stage (ADAM10Δ/Δmb1-cre+/- mice), does not alter immature B
cell development. However, consistent with previous work, MZ B cell
development

was

impaired24.

ADAM10

deletion

in

mature

B

cells

(ADAM10Δ/ΔCD19-cre+/- mice) resulted in a dramatic defect in GC formation and
antibody

responses,

accompanied

with

changes

in

splenic

and

LN

architecture181. On the other hand, deletion of ADAM10 within germinal centers
(ADAM10Δ/ΔIgG1-cre+/- mice) did not impair GC B cells numbers nor lymphoid
architecture, but still led to dramatic defects in humoral responses due to altered
PC gene expression.
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Table 4. List of Relevant ADAM10 substrates
Substrate
CD23

Function
Low

affinity

IgE

receptor;

Reference
Important

for

182

pro-

183

regulating IgE production
IL-6

Ubiquitously

expressed;

Involved

Receptor

inflammatory responses

Notch

Important for cell differentiation

in

24,174

Receptors
CXCL16

Chemokine produced by dendritic cells in T cell

184

area of secondary lymphoid tissues
TNF-α

Pro-inflammatory cytokine, also involved in

185

lymphoid tissue development
Fas Ligand Cytokine involved in cell death; interacts with
(CD95L)

Fas

CD40

Protein important for B cell activation. T cell

Ligand

expressed.

RANK

Important for dendritic cell maturation, LN

Ligand

development and osteogenesis

CX3CL1

Important for leukocyte migration
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186

187

188

189

Figure 2. ADAM structure.
ADAMs are composed of multiple domains, as depicted in this figure.
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Figure 3. Notch signaling
ADAM10-mediated RIP of Notch2 is required for MZ B cell development25. The
Notch2 heterodimer on B cells binds ligands, Jagged 1–2 and Delta-like 1,
present on stromal and antigen presenting cells. Binding initiates sequential
cleavage events by ADAM10 (S2 cleavage) and γ-secretase complex (S3
cleavage). Cleavage releases the Notch2 intracellular domain (N2ICD).
Transport of the N2ICD to the nucleus followed by binding to the transcription
factor RBP-Jκ allows the release of co-repressors (CoR) and attraction of coactivators (CoA) to the transcriptional complex. The activated complex
transcribes Notch target genes, including CD21/35, Deltex-1, Hes 1, and Hes 5,
that promote development of MZ B cells. Deletion of ADAM10, Notch2, and RBPJκ from B cells, or Delta-like 1 from stromal cells prevents MZ B cell
development.
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Fig. 1. ADAM10-mediated RIP of Notch2 is required for Marginal Zone B cell development. Signaling through the Notch2 receptor expressed on transitional B cells
directs marginal zone B cell differentiation (Saito et al., 2003). The Notch2 heterodimer on B cells binds ligands, Jagged 1–2 and Delta-like 1, present on stromal and
antigen presenting cells. Binding initiates sequential cleavage events by ADAM10 (S2
cleavage) and a !-secretase complex (S3 cleavage). Cleavage releases the Notch2
, transacintracellular domain (N2ICD), containing RAM , nuclear localization
, EGF-repeat
, and PEST domains
. Transport of the N2ICD
tivating (TAD)
to the nucleus followed by binding to the transcription factor, RBP-J", allows the
release of co-repressors (CoR), and attraction of co-activators (CoA) to the transcriptional complex. The activated complex transcribes Notch target genes, including
CD21/35, Deltex-1, Hes 1, and Hes 5, that promote development of marginal zone
B cells. Deletion of ADAM10, Notch2, and RBP-J" from B cells, or Delta-like 1 from
stromal cells prevents marginal zone B cell development.
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direct contrast to studies of kuz in drosophila, the authors could
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not rule out a role for ADAM10 in Notch cleavage, and suggested
that ADAM10 and ADAM17 may be functionally redundant in vivo.
This conclusion was supported by later in vitro studies demon-

3.2 ADAM10 and early B cell development
ADAM10 expression in early B cell subsets
ADAM10 plays a key role in Notch signaling. While it is well established
that Notch1 signaling is essential for the commitment to T-cell lineage176, whether
or not ADAM10 plays a role in early B cell development post-lineage commitment
has not been formally investigated. It has been previously reported that ADAM10
is expressed in B cell populations within the spleen, including MZBs and FOB
cells24. In order to further characterize ADAM10 expression in the B cell lineage,
bone marrow cells were isolated and analyzed by flow cytometry for ADAM10
surface expression. This study revealed that ADAM10 is expressed in early B cell
progenitors, including pro-B cells, pre-B cells, and immature B cells (Figure 4).
This data suggested that ADAM10 might be involved in early B cell development.

Generation of early B cell specific ADAM10 deficient mice
Our lab has recently generated B cell-specific ADAM10 knockout mice
(ADAM10Δ/ΔCD19-cre+) by crossing mice with homozygous floxxed ADAM10
(ADAM10-flox) with CD19-cre animals (CD19-cre+)190. Flow cytometry and
immunohistochemical analysis revealed that ADAM10Δ/ΔCD19-cre+ lacked
marginal zone B cells (MZBs), had dramatically reduced numbers of pre-MZBs,
and a significant increase in follicular B cells (FOB)24.
While CD19 expression can be detected starting at the pro-B cell
stage8, CD19-cre mediates efficient recombination of loxP-flanked genes in
mature cells and, to a lesser degree, in immature B and pre-B cells (see
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introduction, section 1.1), leading to recombination in a limited number of bone
marrow B cells147.
Given that cre recombinase is poorly expressed in early B cells when
under the control of the CD19-promoter, we investigated another B cell specific
cre mouse line. The mb1-cre mouse line was obtained from the Reth
laboratory147. The mb1 gene encodes the Igα signaling subunit of the B cell
receptor191 and it is expressed very early in B cell lineage, beginning at the pro-B
cell stage49. Couple to Igβ, it facilitates antigen binding192. In order to compare
the level of recombination that occurs in the BM when Cre recombinase is
expressed under the control of CD19 promoter or mb1 promoter, we took
advantage of YFP reporter mice. The YFP reporter mouse line expresses YFP
after cre-mediated recombination. BM cells were isolated from mb1-cre+YFP+
and CD19-cre+YFP+ mice. The percentage of CD19+YFP+ B cells was then
compared between the two lines. Consistent with published results, mb1-cre
mice showed much more efficient recombination (Figure 5). While nearly all
CD19+ B cells (98.9%) were YFP+ in BM of mb1-cre+ mice, only 10% of CD19+ B
cells had undergone cre-mediated recombination in CD19-cre+ mice. These
results support the concept that CD19-cre mouse models are not well suited for
the generation early B cell-specific knockout mice.

ADAM10 is dispensable for early B cell development
Spleen and BM cells were isolated from 8- to 12- week old
ADAM10Δ/Δmb1-cre+ animals and control animals (ADAM10Δ/Δmb1-cre- mice). B
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cell populations were analyzed by flow cytometry. In the BM, the percentage of
immature B cells, defined as B220+IgM+ and pro/pre-B cells, defined as
B220+IgM-, was comparable between ADAM10Δ/Δmb1-cre+/- and WT controls
(Figure 6). Consistent with this finding, recently published work demonstrated
that B cells developed normally in the presence of ADAM10-inhibitors in an in
vitro model of hematopoiesis193. These results demonstrate that ADAM10 is
dispensable for early B cell development. Consistent with previously published
results, ADAM10Δ/Δmb1-cre+/- mice lacked MZ B cells in the spleen (Figure 7)
(MZ B cells are described in section 1.2)24.
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Figure 4. ADAM10 expression in bone marrow B cells.
Bone marrow derived cells isolated from C57BL/6 mice were stained for B220,
IgM, CD43, and ADAM10. B cell subsets were defined as follows: Pro-B cells:
B220+CD43+IgM-; Pre-B: B220+CD43-IgM+; and immature B cell: B220+IgM+.Blue
represents sample while gray represent isotype control. MFI; mean fluorescent
intensity. Experiment was carried out 3 times with similar results. Two mice of
each genotype per experiment.
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Figure 5. Comparison of recombination efficiency between mb1-cre and
CD19-cre mouse models.
Bone marrow cells from CD19-cre+YFP+ or mb-1-cre+YFP+ mice were stained for
CD19 and analyzed by flow cytometry. The percentage of CD19+YFP+ is
displayed in the upper right quadrant of each FACS plot.
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Figure 6. ADAM10 is dispensable for early B cell development.
Bone marrow cells were isolated from ADAM10Δ/Δmb1-cre+/- and WT mice and
analyzed via flow cytometry for immature (B220+IgM+) and pro/pre-B cells
(B220+IgM-). Representative contour plots are shown. Experiment was carried
out 3 times with similar results. Two mice of each genotype per experiment.
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Figure 7. ADAM10 is required for marginal zone B cell development.
Spleen cells were isolated from ADAM10Δ/Δmb1-cre+/- and WT mice and
analyzed via flow cytometry for follicular (B220+CD23hiCD21/35+IgM+) (blue) and
pre-MZB (B220+CD23hiCD21/35hiIgMhi) (red) [top] and marginal zone B cells
(B220+CD23loCD21/35hiIgM+) [bottom]. Representative contour plots are shown.
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3.3 ADAM10 is essential for Germinal Center formation and maintenance of
lymphoid architecture
ADAM10 is highly expressed in GC B cells
ADAM10 cleaves a variety of substrates that have been associated with
humoral responses, such as TNF-α, Notch1, Notch2, and CD23174,182,185. We
therefore sought to determine the role of ADAM10 in GC formation and antibody
production. Delineation of ADAM10 expression patterns in B cells is an important
step toward understanding the potential role of the proteinase in humoral
immunity. Flow cytometry analysis demonstrated that within Peyer’s patches,
while less than 2% of naïve B cells expressed ADAM10, over 80% of GC B cells
were ADAM10+ (Figure 8A,B). The flow cytometry results were confirmed by
immunohistochemistry of Peyer’s patches stained for ADAM10, PNA, and IgD.
Consistent with our flow cytometry results, ADAM10 was highly expressed by
cells within GCs (Figure 8C). Peyer’s patches were chosen due to the expected
high level of GC activation.

Humoral immune responses in ADAM10B-/- deficient mice
Given the significant expression of ADAM10 in GC B cells, we
investigated its role in humoral responses by using B cell specific ADAM10deficient mice (ADAM10B-/-). Basal levels of serum IgM, IgG1, IgG2a, and IgG2b
were significantly reduced in ADAM10B-/- mice when compared to WT, suggesting
a defect in antibody production (Figure 9A). To directly assess antigen-specific
63

antibody production, ADAM10B-/- mice were immunized i.p. with NP-KLH, and
serum levels of NP-specific antibodies were examined. ADAM10B-/- mice showed
reduced levels of NP-specific IgM 7 days post-immunization. However, levels
reached WT values by day 21 and through the remainder of the experiment
(Figure 9B). In contrast, NP-specific IgG levels, both total and high affinity, were
reduced for 4 weeks post-immunization (Figure 9B). This reduction in IgG was
not specific to a particular isotype, as antigen-specific IgG1, IgG2a, and IgG2b
were dramatically reduced in ADAM10B-/- mice (Figure 10A). Furthermore, even
when immunized with a high antigen dose of 1mg of NP-KLH, ADAM10B-/- mice
failed to mount a normal antibody response. This result demonstrates that the
defect in antibody production cannot be overcome by simply providing more
antigen (Figure 10B).
To test if memory responses were also impaired in ADAM10B-/- mice, WT
controls and ADAM10B-/- mice were immunized and boosted 42 days later.
Consistent with data shown in Figure 8B, ADAM10B-/- mice had decreased levels
of antigen-specific antibodies after primary immunization. Moreover, while WT
controls exhibited a 12-fold increase in anti-NP IgG antibodies 5 days after
secondary immunization (from 38.34 +/- 25 to 461.5 +/- 72.45), ADAM10B-/- mice
only had a 4-fold increase (from 3.133 +/- 2.888 to 12.36 +/- 6.4460).
Furthermore, 5 days after boost, WT mice produced 16 times more high affinity
antigen-specific IgG and 37 times more total NP-specific IgG than ADAM10B-/mice (Figure 9C). These results demonstrate that in ADAM10B-/- mice both
primary and recall antibody responses are impaired.
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Fewer NP-specific Antibody Secreting Cells are observed in ADAM10B-/- mice
Given the severe defect in antibody production observed in ADAM10B-/-,
mice we hypothesized that the generation of antigen-specific PCs was impaired.
Examination of antibody secreting cells (ASCs) by ELISPOT assays showed that
immunized ADAM10B-/- mice had drastically reduced numbers of NP-specific
ASCs in the spleens and BM 21 days post-immunization (Figure 11A,B). Similar
results were observed in spleens 14 and 28 days after immunization
(Figure11D,E). Together, these results demonstrate that the decrease in splenic
ASCs is not due to altered migration or preferential localization to the BM, but
likely due to impairments in PC differentiation and/or survival.
A critical component of the humoral response is affinity maturation. Thus,
we next examined affinity maturation in immunized ADAM10B-/- mice. While 21
days after immunization most ASCs were secreting high affinity antibodies in WT
controls, the few ASCs that were present in ADAM10B-/- mice were secreting low
affinity Ab. WT controls had 12-fold higher number of NP-specific ASCs and 20fold higher number of NP-specific ASCs producing high affinity antibodies when
compared to ADAM10B-/- mice. Moreover, when the ratio of high affinity and total
ASCs was calculated, it was evident that the generation of high affinity ASCs in
ADAM10B-/- mice was especially affected (Figure 11C). These results suggest a
defect in affinity maturation in ADAM10B-/- mice.
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GC formation is impaired in ADAM10B-/- mice
As demonstrated in Figure 10, that antigen-specific ASCs were reduced in
immunized ADAM10B-/- mice. Being that long-lived PCs and memory cells are
generated within GCs31, GC formation in ADAM10B-/- mice was examined. GC B
cells, defined as IgMloIgDloB220+IgG1+CD38lo were enumerated by flow
cytometry194 (Figure 12A). Remarkably, the number and percentage of GC B
cells within the spleen was dramatically decreased in ADAM10B-/- mice (Figure
12B,C). Similar results were obtained when GC B cells were defined as
B220+GL7+Fashi (Figure 12D). Activation induced cytosine deaminase (AID) is
essential for SHM and CSR, two events that occur within GCs80,195. Therefore,
consistent with a decrease in the number of GC B cells, AID expression was also
decreased in draining LN of ADAM10B-/- mice compared to that of WT (Figure
13).

ADAM10B-/- mice have altered splenic and lymph node architecture
In order to better understand the relationship between decreased GC B
cells and the defects in antibody production observed, GC formation in
immunized mice was assessed by immunohistochemistry. As depicted in Figure
14A, while several GCs could be detected in WT controls, as determined by GL7+ positive cells, draining LN of ADAM10B-/- mice contained a paucity of GL7+
clusters. Interestingly, GL7+ cells were scattered throughout the LN of ADAM10B/-

mice (Figure 14A). Given the unusual pattern of GL-7 expression, we analyzed

B- and T cell localization within the LN. Surprisingly, the distribution of B cells
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and T cells was aberrant, suggesting that B cell specific ADAM10 deletion leads
to changes in LN structure (Figure 14B). In contrast, LN structure in non-draining
nodes or unimmunized mice was normal with regards to B- and T cell
segregation. However, B cell follicles appeared thin, reminiscent of TNF-α and
LTβ- deficient mice (Figure 14D)14,196.
Given that FDCs play a crucial role in GC formation and lymphoid tissue
structure18,197,198, we stained draining LN sections for FDC with CD21/35 (CR2).
FDCs are known to upregulate CD21/35 subsequent to activation199. Consistent
with an absence in GCs and disorganized lymphoid architecture, FDC networks
were not detected in LN and spleen from ADAM10B-/- mice (Figure 14C, Figure
15D). Unlike the draining LN, GL7 staining was not detected in spleen of
ADAM10B-/- mice (Figure 15A). However, although normal in unimmunized mice,
splenic architecture was also clearly altered post-immunization (Figure 15B,C).

ADAM10B-/- mice have dysregulated chemokine expression following antigen
challenge
The organization of secondary lymphoid tissues is highly regulated by
chemokine gradients. To determine if the changes in structure observed were
accompanied by altered chemokine expression, chemokine expression in
draining and non-draining LN was assessed by qPCR. As expected, non-draining
LN from WT and ADAM10B-/- mice had similar CXCL13, CCL19 and CCL21
expression (Figure 16A). In sharp contrast, draining LN isolated from ADAM10B-/mice exhibited increased CCL21 expression, while CXCL13 levels were
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comparable. CCL19 levels trended higher, but the increase was not statistically
significant (Figure 16B). Analysis of CCL21 expression by immunohistochemistry
revealed an expanded area of CCL21 staining in the ADAM10B-/- LN (Figure
16C), consistent with the localization of T cells within draining lymph nodes
(Figure 14B). These results demonstrate that B cell expressed ADAM10 is
important for maintenance of lymphoid architecture and regulation of chemokine
expression during active immune responses.
Despite having normal levels CXCL13 expression, ADAM10B-/- showed an
abnormal pattern of B-cell localization secondary to antigen challenge. We
therefore decided to investigate whether ADAM10-deficient B cells showed
altered migration to the B cell chemoattractants, CXCL13 and CXCL12.
Interestingly, ADAM10-deficient B cells showed enhanced migration to CXCL13,
but not CXCL12 (Figure 17), despite having normal receptor expression (Figure
18).

B cell specific ADAM10 deletion leads to structural changes in naïve LN
Given the abnormal appearance of B cell follicles in LN isolated from
ADAM10B-/- mice, we decided to look at other features of lymph node
architecture, such as collagen deposition and stromal cell populations. While
collagen is heavily deposited within the T-cell zone of lymph nodes, B cell
follicles seem to have very few collagen fibers200. As depicted in Figure 19, LN
isolated from ADAM10B-/- showed excessive collagen deposition when compared
to WT LN. Where in WT LN, B cell follicles showed sparse collagen deposition,
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collagen was detected throughout the LN of ADAM10B-/- mice. ADAM10 has been
demonstrated to have collagenase capacity201, so it is possible that B cell
expressed ADAM10 is required for collagen breakdown within B cell follicles;
therefore, in the absence of ADAM10, collagen deposition is increased. These
results are consistent with abnormal LN development.
There are several subsets of stromal cells present in LN. They are CD45-,
as they are not of hematopoietic origin, and can be further divided into four
categories based on their expression of CD31 and gp38, also known as
podoplanin or pdp. Fibroblastic reticular cells (FRCs) are defined as gp38+CD31-;
lymph endothelial cells (LECs) are defined as gp38+CD31+ and blood endothelial
cells (BECs) are defined as gp38-CD31+. gp38-CD31- cells are a heterogeneous
population of stromal cells–FDCs are thought to be represented in this
population19. The FRC subset is mostly composed of T cell zone reticular cells,
also referred to TRCs. These are the cells responsible for producing CCL21 and
CCL19, and thus, for the regulation of T cell homing19. Given the increase in
CCL21 and CCL19 in draining LN from ADAM10B-/- and the thinning of the B cell
follicles, we hypothesized that LNs from ADAM10B-/- would have increased FRC
numbers. Indeed, there was a relative increase in FRCs in LN from aged
ADAM10B-/- (16-20 weeks) (Figure 20). Interestingly, when the experiment was
repeated with young mice 4 weeks of age, there was a reduction in the
proportion of FRCs and an increase in BECs (Figure 21). These results
demonstrate that ADAM10 deletion from B cells leads to loss of FDCs as well as
alterations in the FRC compartment.
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ADAM10-deficient B cells secrete less TNF-α following in vitro stimulation
As previously mentioned, the LN appearance of ADAM10B-/- mice was
similar to that of TNF-α deficient mice. Being that ADAM10 has been shown to
cleave TNF-α and that B-cell TNF-α is important for lymphoid tissue
development185,202, we sought to determine whether ADAM10-deficient B cell
produce less TNF-α following activation. Indeed, studies showed that subsequent
to LPS stimulation a significantly decreased amount of TNF-α could be detected
in supernatant of ADAM10-deficient B cells, despite normal TNF-α mRNA
expression (Figure 22). Further studies are needed to determine whether
decrease TNF-α release is the mechanism underlying the changes in
architecture and defects in humoral responses observed in ADAM10B-/- mice.

Defect in humoral responses in ADAM10B-/- mice is Notch2 and CD23independent.
Recent studies have suggested that Notch signaling was involved in
antibody production and ASC differentiation177,178. ADAM10 is critical for the
initiation of Notch signaling. To determine if the antibody production defects were
due to impaired Notch signaling, we generated mice that lack ADAM10 and have
constitutively active Notch2 signaling in a B cell specific manner (ADAM10B-/N2ICD-TgB+). As expected, expression of N2ICD recovered MZ B cell
development in these mice, demonstrating that the transgene was indeed active
(Figure

23A).

WT,

ADAM10B-/-

and
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ADAM10B-/-N2ICD-TgB+

mice

were

immunized. Consistent with previous experiments, ADAM10B-/- mice had
significantly reduced levels of NP-specific antibodies. Importantly, introduction of
N2ICD transgene failed to rescue the defect in antibody production and GC
formation. Moreover, it did not prevent changes in LN architecture (Figure
23B,C). These results demonstrate that increased Notch signaling cannot rescue
the defects in humoral responses.
We have recently reported that ADAM10 is responsible for the cleavage of
the low affinity IgE receptor, CD23182, and consequently, ADAM10-deficient B
cells have increased CD23 expression24,123. Studies have revealed that CD23
overexpression leads to decreased IgG1 and IgE production55,145. However,
when CD23Tg mice were immunized with NP-KLH, analysis of NP-specific IgG
levels indicated that CD23Tg mice had a normal antibody response to NP-KLH
(Figure 24). Furthermore, it has been previously reported that CD23Tg mice form
GCs following immunization with T-dependent antigens. It should be noted that
the GCs observed in CD23Tg mice had a more globular appearance than WT203.
These results suggest that the humoral defect observed in ADAM10B-/- mice is
not secondary to CD23 overexpression, however, this should be more carefully
addressed. Another relevant ADAM10 substrate is CXC3CL1 (see below).

CX3CR1 deficient mice have enhanced humoral responses
Another ADAM10 substrate is CX3CL1, also known as fractalkine in
humans and neurotactin in mice204,205. CX3CL1 mediates its function through
binding to its receptor CX3CR168,70,148. CX3CL1 is a chemokine that exists in two
71

forms; the membrane bound form mediates leukocyte adhesion, while the soluble
for acts as a conventional chemokine, attracting monocytes, NK cells, T cells and
B cells125,206,207.

Recent studies have suggested a role of CX3CR1/CX3CL1

signaling axis in GC formation and antibody responses. Studies have
demonstrated that GC B cells migrate to CX3CL134,208. Moreover, it has been
suggested that TFH and FDCs secrete CX3CL1 and that through this mechanism,
they promote GC B cell survival35,207. Interestingly, CX3CR1-deficient mice
showed decreased basal levels of IgM but increased IgG1 levels (Figure 25).
These results suggest enhanced class switch recombination.
Given that CX3CR1-deficient mice had altered basal antibody levels, we
decided to assess antigen specific antibody responses. To this end, WT and
CX3CR1-deficient mice were immunized the NP-KLH and GC formation and
antibody production were determined. Despite having a slight, but statistically
significant decrease in the percentage of GC B cells, CX3CR1-deficient mice had
an enhanced antibody response to NP-KLH immunization (Figure 26). Further
studies will be required in order to elucidate the mechanism undelaying this
phenotype.

Antibody production in ADAM10B-/- mice can be partially rescued by repeated
immunization
Very often, murine immunization protocols involve an initial immunization
and a challenge two weeks later. When this immunization schedule was carried
out with ADAM10B-/- mice, we were surprised to see that total NP-specific IgG
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levels were similar between WT and ADAM10B-/- mice. On the other hand, high
affinity NP-specific IgG levels were still significantly lower following the boost
(Figure 27A). Similar results were obtained when NP-specific PCs were
quantified by ELISPOT (Figure 27B). Immunohistochemistry analysis should be
carried out in this system in order to determine whether repeated immunization
rescues GC formation and changes in architecture.
A key difference between a primary immunization and secondary
immunization is the presence of pre-existing antibodies and the formation of
immunine complexes. Given that antibody production was partially rescued by
repeated immunization, we hypothesized that the antibody defects observed in
ADAM10B-/- mice could be rescued by immunization with immune complexes. WT
and ADAM10B-/- mice were immunized with NP-OVA or NP-OVA and anti-OVA
antibodies (IC). Mice were bled five days later and the presence of NP-specific
IgM and IgG1 was assessed by ELISA. Surprisingly, WT mice, whether they
received antigen alone or immune complexes produced significantly more NPspecific IgM than ADAM10B-/- mice (Figure 28A). Regarding NP-specific IgG1,
levels were only detectable in WT mice that received immune complexes. In
ADAM10B-/- mice, NP-specific IgG1 was not detected in either group (Figure
28B). These results demonstrate that immunization with immune complexes
does not rescue antibody production defect. However, it is possible that if mice
were analyzed at a later time point, antibody production might be restored to WT
levels, thus suggesting a kinetics defect.
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Defective antibody production seen in ADAM10B-/- mice might be explained by
decreased B cell help
We have demonstrated that ADAM10B-/- mice have impaired antibody
responses to T-dependent antigens as well as changes in splenic and LN
architecture. In order to assess whether the decreased antibody levels result
from a B cell intrinsic defect, splenocytes were stimulated with CD40L and IL-4 in
vitro. Interestingly, WT and ADAM10-null B cells made comparable amounts of
IgG1 (Figure 29A) demonstrating that when adequately stimulated, ADAM10-null
B cells are able to class switch normally.
TFH cells provide B cell help via CD40L, IL-21 and IL-4 and play important
roles in GC B cell survival, affinity maturation and terminal differentiation to
PCs51,52,209,210. TFH cells are characterized by high expression of CXCR5 and PD1, and IL-21 production210. Given our in vitro findings and the changes in
architecture observed in ADAM10B-/- mice, we hypothesized that the defects in
humoral responses observed resulted from inadequate B cell stimulation and
decreased T cell help. Results revealed that TFH development and/or
maintenance was impaired in ADAM10B-/- mice, as fewer TFH cells were present
in draining lymph nodes of ADAM10B-/- mice (Figure 29B). Consistent with
decreased number of TFH cells, IL-21 message levels were also reduced in vivo
(Figure 29C). These results demonstrate that while ADAM10 deficient B cells can
produce normal levels of antibody in vitro when stimulated with anti-CD40 and IL-
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4, they are unable to class switch efficiently in vivo likely due to decreased T cell
help.
Surprisingly, when ADAM10-deficient B cells were stimulated in vitro with
LPS, they failed to produce normal antibody levels despite normal proliferations
(Figure 30). These results demonstrate that ADAM10-deficient B cells respond
differently to different types of stimuli. Moreover, in vitro stimulation is very
different from in vivo B cell stimulation and it has been reported to yield different
results regarding PC differentiation72,135. Therefore, the role of ADAM10 in PC
differentiation and function warranted a more careful evaluation. ADAM10
regulation of PC function will be discussed in section 3.4.
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Figure 8. ADAM10 expression on GC B cells.
(A-B) Expression of ADAM10 on gated germinal center PNAhi IgDlo (blue) and
naive PNAloIgDhi (red) B (CD19+) cells isolated from Peyer’s patches. Flow
cytometry gates used to define the germinal center and naïve B cell populations
are indicated in left. To demonstrate specificity of staining, an isotype-matched
monoclonal antibody was used (isotype). (A) Gating protocol is shown. (B)
Percentage of ADAM10+ cells in naive and GC B cells. (C) Frozen serial sections
of Peyer’s patches were stained to detect B cell follicles (B220+, blue), germinal
centers (PNA+, green) and ADAM10 (red) (right panel). To demonstrate
specificity of staining, isotype-matched mAb were used instead of mAb against
ADAM10 (left panel). Original magnification: x20. The mucosal epithelium (E)
also reacts with PNA and anti-ADAM10. Figure courtesy of Joanna Cichy,from
Jagiellonian University, Krakow, Poland.
.

76

77

Figure 9. ADAM10B-/- mice have impaired humoral responses.
(A) Serum IgM, IgG1, IgG2a and IgG2b were measured by ELISA from nonmanipulated 8-12 week old mice. (B) ADAM10B-/- mice and WT controls were
immunized with 10µg NP-KLH emulsified in alum. At the indicated times, serum
samples were collected and total NP-specific IgM, total IgG and high affinity IgG
antibody titers were determined by ELISA with NP14BSA as capture antigen for
total and NP4BSA for high affinity ELISA. (C) Mice were immunized with NP-KLH
emulsified in alum, rested for 42 days, and boosted with 10µg NP-KLH for 5
days. Mice were bled weekly throughout the course of the experiment. Total and
high affinity IgG levels were measured by ELISA at each time point. The relative
unit (RU) values for alum-injected mice were less than 0.001. Bars represent the
mean ± SE of 5-9 mice per group (*p < 0.05, **p<0.01, ***p<0.001). Data
represent results obtained in at least two independent experiments.

78

79

Figure 10. Decreased NP-specific IgG secretion is not IgG subset and
cannot be overcome by high antigen dose
(A) ADAM10B-/- mice and WT controls were immunized with NP-KLH emulsified
in alum. Twenty-eight days after primary immunization, samples were collected
and NP-specific IgG1, IgG2a and IgG2b antibody titers were determined by
ELISA with NP14BSA as capture antigen. (B) ADAM10B-/- and WT controls were
immunized i.p. with 1mg of NP-KLH emulsified in alum. Samples were collected
at the indicated time post immunization and NP-specific antibodies were
measured. The relative unit (RU) values for alum-injected mice were less than
0.001. Bars represent the mean ± SEM of 5 mice per group. Data represent
results obtained in two independent experiments. (*p<0.05, **p<0.01, ***p<0.001)
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Figure 11. ADAM10B-/- mice have decreased number of antigen specific
ASCs.
ELISPOT analysis of cells producing (A) total (both low and high affinity), (B)
high-affinity NP-specific IgG and (C) high versus total ratio present in spleen (top)
and bone marrow (bottom) isolated from WT and ADAM10B-/- mice 21 days postimmunization with NP-KLH emulsified in alum. (D-E) ELISPOT analysis of cells in
spleen producing (D) total and (E) high affinity NP-specific IgG 14 and 28 days
post-immunization. (*p <0.05, **p<0.01, ***p <0.001). Bars represent the mean 6
SE of five mice per group. Data represent results obtained in two independent
experiments.
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Figure 12. GC formation development following immunization
ADAM10B-/- and WT mice were immunized with 10 µg NP-KLH emulsified in
alum. Fourteen and twenty one days post immunization flow cytometry was
carried out and the presence of GC B cells (IgMloIgDloB220+IgG1+CD38-) in
spleen was assessed. Staining protocol is depicted (A). Both percentage (B) and
total number (C) of GCs were enumerated. (D) Mice were immunized as in A-C.
GC B cells were quantified by flow cytometry as B220+GL7+Fashi fourteen days
post-immunization. (*p<0.05, **p<0.01). Bars represent the mean ± SE of 3-8
mice per group. Data are representative of 3 independent experiments.
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Figure 13. Aidca expression in draining lymph nodes.
Mice were immunized in the footpad with 10µg of NP-KLH. Fourteen days after
immunization, draining LN were isolated and Aidca expression was analyzed by
qPCR. Bars represent the mean ± SE of 8 mice per group. Data are
representative of 2 independent experiments.
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Figure 14. Immunohistochemistry analysis of GC formation and lymph
node architecture following T-dependent immunization.
ADAM10B-/- and WT mice were immunized with 10µg NP-KLH emulsified in alum.
Fourteen days after immunization, draining LN were sectioned and stained for
(A) GL7 (green) and IgD (red); (B) Thy1.2 (green) and B220 (red); (C) CD21/35
(green) and B220 (red). (D) non-draining LN were also stained with CD3 (green)
and B220 (red). Pictures are representative of 3 independent experiments.
Magnification displayed is 20x.
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Figure 15. Immunohistochemistry analysis of GC formation and splenic
architecture following T-dependent immunization.
ADAM10B-/- and WT mice were immunized with 10µg NP-KLH emulsified in alum.
Fourteen days after NP-KLH immunization, spleens were isolated and sectioned.
Sections stained for (A) GL7 (green) and IgD (red) or (C) Thy 1.2 (green) and
B220 (red) or (D) B220 (red) and CD21/35 (green). (B) Spleens isolated from
naïve animals, sectioned and stained for Thy 1.2 (green) and B220 (red).
Pictures are representative of 3 independent experiments. Magnification
displayed is 20x for A and B, and 10x for C and D.
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Figure 16. Chemokine expression in draining lymph nodes.
Mice were immunized in the footpad with 10µg of NP-KLH. Fourteen days after
immunization, draining and non-draining LN were isolated and chemokine
expression was analyzed by qPCR for CCL19, CCL21 and CXCL13. Nondraining (A) and draining (B) LN are shown. (*p<0.05). Bars represent the
mean ± SE of 8 mice per group. Data are representative of 2 independent
experiments. (C) Draining LN were stained for CCL21. White line depicts lymph
node capsule. Pictures are representative of 3 mice per group.
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Figure 17. ADAM10-deficient B cells show enhanced migration to CXCL13
but not CXCL12.
Splenocytes from WT and ADAM10 were isolated and migration was assayed as
described in methods section. (Top) 1µg/mL of CXCL13; (bottom) 300ng/mL of
CXCL12. (***p<0.001, 1-way ANOVA with Tukey post-test). Bars represent the
mean ± SE of 4-6 mice per group. Data are representative of 3 independent
experiments.

94

CXCL13 (% of input)

80

***

60

40

20

0

CXCL13

-

+

-

+

CXCL12 (% of input)

50

WT
ADAM10B-/-

40
30
20
10
0

CXCL12

-

+

-

95

+

Figure 18. ADAM10-deficient B cells have normal CXCR5 expression.
Splenocytes were isolated and stained for B220 and CXCR5. (A) Histogram
demonstrating CXCR5 B cells expression in WT (---) and ADAM10-deficient B
cells (shaded light blue). Isotype control is also depicted (shaded light gray). (B)
Quantification of mean fluorescence intensity (MFI). Bars represent the
mean ± SE of 4-6 mice per group. Data are representative of 3 independent
experiments.
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Figure 19. Lymph nodes isolated from ADAM10B-/- mice show abnormal
collagen deposition.
Lymph nodes were isolated from naïve WT and ADAM10B-/- mice, sectioned and
stained

for

collagen

type

II.

Representative

pictures

are

displayed.

Immunohistochemistry was performed and analyzed by Mohey Eldin El Shikh.
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Figure 20. B cell-specific ADAM10 deletion alters stromal cell populations
in aged mice.
Naïve LN were isolated from 16-20 week old mice and single cell suspension
was generated by enzymatic digestion, as described in methods section. Cells
were stained and stromal cell populations were analyzed. FRCs are gp38+CD31-;
LECs are gp38+CD31+, BECs are gp38-CD31+. Double negative (DN) cells are
gp38-CD31-(A) Representative contour plot. (B) quantification. Bars represent the
mean ± SE of 4-6 mice per group. Red boxes represent populations that are
different between WT and ADAM10B-/- mice. Data are representative of 3
independent experiments. (*p<0.05, ***p<0.001).
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Figure 21. B cell-specific ADAM10 deletion alters stromal cell populations
in young mice
Naïve LN were isolated from 4 week old mice and single cell suspension was
generated by enzymatic digestion, as described in methods section. Cells were
stained and stromal cell populations were analyzed. FRCs are gp38+CD31-;
LECs are gp38+CD31+, BECs are gp38-CD31+. Double negative (DN) cells are
gp38-CD31-(A) Representative contour plot. (B) quantification. Bars represent the
mean ± SE of 4-6 mice per group. Red boxes represent populations that are
different between WT and ADAM10B-/- mice. Data are representative of 3
independent experiments. (*p<0.05, ***p<0.001).
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Figure 22. ADAM10 deficient B cells secrete reduced amounts of TNF-α
following LPS stimulation.
WT and ADAM10-deficient naïve B cells were isolated via magnetic bead
separation. Cells were stimulated with 10µg/mL of LPS. Three days after
stimulation (A) supernatant was harvest and TNF-α was measured by ELISA and
(B) TNF-α mRNA expression was determined by qPCR. Bars represent the mean
± SE of 6 mice per group. Data represent results obtained in three independent
experiments. (***p<0.001).
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Figure 23. Defect in humoral responses in ADAM10B-/- mice seems to be
Notch2-independent.
(A) Splenocytes isolated from ADAM10B-/-, ADAM10B-/-N2ICD-TgB+ and WT mice
were stained with B220, CD23, CD21/35 and IgM. Marginal zone B cells were
defined as B220+CD23-/loCD21/35hiIgM+. (B) Mice were immunized in the footpad
with NP-KLH, 14 days later draining LN were isolated and stained for GL7 and
IgD (top) and Thy1.2 and B220 (bottom). (C) ADAM10B-/-, ADAM10B-/-N2ICD-TgB+
and WT mice were immunized i.p. with NP-KLH emulsified in alum. At the
indicated times, serum samples were collected and total NP-specific IgG was
determined by ELISA. Bars represent the mean ± SE of 5 mice per group. Data
represent results obtained in two independent experiments. (*p<0.05, **p<0.01,
***p<0.001, One-way ANOVA with Turkey post-test). Significance refers to
ADAM10B-/- compared to WT and ADAM10B-/-N2ICD-TgB+ compared to WT.
ADAM10B-/- and ADAM10B-/-N2ICD-TgB+ were not different from each other at any
time point.
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Figure 24. CD23Tg mice have a normal IgG response to NP-KLH
CD23Tg and WT mice were immunized with NP-KLH emulsified in alum. At the
indicated times, serum samples were collected and total NP-specific IgG was
determined by ELISA. Bars represent the mean ± SE of 8 mice per group. Data
represent results obtained in two independent experiments.
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Figure 25. Basal antibody levels in CX3CR1-deficient mice.
Serum

(A) IgM, and (B) IgG1 were measured by capture ELISA from non-

manipulated 8-12 week old mice. Bars represent the mean ± SE of 9-15 mice per
group (*p < 0.05). Data represent results obtained in at least two independent
experiments.
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Figure 26. CX3CR1-deficient mice have enhanced antibody responses.
CX3CR1-deficient mice and WT controls were immunized with 10µg NP-KLH
emulsified in alum. At the indicated times, serum samples were collected and
total NP-specific

(A) total IgG and (B) high affinity IgG antibody titers were

determined by ELISA with NP14BSA as capture antigen for total and NP4BSA for
high affinity ELISA. (C) Mice were immunized with NP-KLH emulsified in alum,
fourteen days post-immunization spleens were harvested and analyzed for GC B
cells by flow cytometry. Quantified results are showed. The relative unit (RU)
values for alum-injected mice were less than 0.001. Bars represent the
mean ± SE of 3-10 mice per group (*p < 0.05, **p<0.01, ***p<0.001).
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Figure 27. Repeated immunization can partially rescue antibody production
defect in ADAM10B-/- mice.
ADAM10B-/- and WT mice were immunized with 10µg NP-KLH emulsified in alum.
Fourteen days after primary immunization, mice were boosted with 10µg NP-KLH
emulsified in alum. (A) Mice were bled weekly and total and high-affinity NPspecific IgG levels were measured by ELISA. (B) Twenty-eight days following
immunization mice were sacrificed and antibody-secreting cells in spleen and
bone marrow were quantified by ELISPOT. The relative unit (RU) values for
alum-injected mice were less than 0.001. Bars represent the mean ± SE of 8-10
mice per group (*p < 0.05, **p<0.01, ***p<0.001).
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Figure 28. Immunization with immune complexes does not rescue antibody
production defects seen in ADAM10B-/- mice.
WT and ADAM10B-/- were passively immunized subcutaneously with 6mg of
rabbit polyclonal anti-OVA antibodies or PBS. Twelve hours later, mice were
injected with 10µ of NP-OVA in alum. Six days later, mice were sacrificed and
cardiac puncture. Antigen-specific (A) IgM and (B) IgG1 were measured by
ELISA. Bars represent the mean ± SE of 4 mice per group (*p < 0.05, **p<0.01).
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Figure 29. Normal responses of ADAM10 deficient B cells under T
dependent stimulation in vitro, but decreased TFH cell numbers in vivo.
(A) Splenocytes were cultured (12.5x106 cells/well) with CD40L-transfected
Chinese hamster ovary (CHO) cells as a B cell stimulant (6x104 cells/well) for
seven days. Supernatants were then harvested and analyzed for IgG1
expression by ELISA. (B-D) Mice were immunized with NP-KLH. Fourteen days
post immunization flow cytometry was carried out and the presence of TFH (B220CD4+CXCR5hiPD-1hi) in the spleen of WT and ADAM10B-/- was assessed. (B).
Staining protocol is depicted. (C). Percentage of TFH out of CD4+ was
enumerated

(D) Draining lymph nodes were analyzed for IL-21 mRNA by

quantitative PCR (*p<0.05, **p<0.01). Bars represent the mean ± SE of 6 mice
per group. Data are representative of 2 independent experiments.
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Figure 30. ADAM10-deficient B cells produce reduced antibody amounts
following LPS stimulation.
Naïve B cells were isolated via magnetic bead separation and stimulated with
10µg/mL of LPS. Four days following stimulation, supernatant were harvest and
analyzed for (A) IgM and (B) IgG1 by ELISA. (C) Two days following challenge,
tritiated thymidine was added to cells. Cells were incubated for 24 hours and then
harvested. Thymidine incorporation was then measured. (**p<0.01, ***P<0.005).
Bars represent the mean ± SE of 6 mice per group. Data are representative of at
least 2 independent experiments.

120

A

B 120

150

50

80

IgG3 (% WT)

100

**

60
2.0
1.5
1.0
0.5
0.0

0

C

***

150000

WT
ADAM10-null

100000

CPM

IgM (% WT)

100

50000

0

LPS

-

+

-

121

+

3.4 ADAM10 regulates plasma cell function
Generation of ADAM10Δ/ΔIgG1+/Members of the ADAM family regulate a variety of functions, including, but
not limited to, cell migration, proliferation and adhesion211. We have previously
generated mice that lacked ADAM10 in all peripheral B cells (ADAM10B-/- mice)
by crossing a knockin mouse strain containing loxP sites surrounding exon 9 of
adam10 (ADAM10Δ/Δ) allele with mice expressing Cre recombinase under the
control of the CD19 promoter24. As discussed in section 3.3, the study of these
mice demonstrated a severe defect in GC formation and changes in lymphoid
architecture181. In order to determine whether ADAM10 plays a role in PC
development or the defects in antibody production observed in ADAM10B-/- were
secondary to changes in architecture, we crossed ADAM10Δ/Δ with IgG1-cre
transgenic mice and generated ADAM10Δ/ΔIgG1-cre+/- mice128. Previous studies
have demonstrated that IgG1-cre transgene shows specificity for GC B cells with
approximately 75% of GC B cells expressing Cre recombinase. Introduction of
the IgG1-cre transgene has been shown to affect IgG1 production; therefore, we
also generated controls that have cre expression but have WT ADAM10 alleles
(ADAM10+/+IgG1-cre+/- mice). In order to track cells that had undergone cremediated recombination, we crossed ADAM10Δ/ΔIgG1-cre+/- and ADAM10+/+IgG1cre+/- mice with R26R-EYFP+ mice, thus, generating ADAM10Δ/ΔIgG1-cre+/-R26REYFP+ (ADAM10Δ/ΔIgG1-cre+/-YFP+) and ADAM10+/+IgG1-cre+/-YFP+ (control)
mice that express EYFP transgene following cre-mediated recombination24,74-76.
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Antibody production and GC formation in ADAM10Δ/ΔIgG1-cre+/-YFP+ mice
Our previous study demonstrated that ADAM10-deletion in all peripheral B
cells (ADAM10B-/- mice) led to severe impairments in antibody production, as
evidenced from decreased antibody responses to T-dependent antigens.
Moreover, GC formation was severely affected in those mice. Furthermore, TFH
cell numbers were also diminished in ADAM10B-/- mice181. In order to determine if
deletion of ADAM10 within GCs affected basal antibody levels, mice were bled
and IgM, IgG1 and IgE levels were measured by ELISA. As depicted in Figure
31A-C, there were no differences between ADAM10Δ/ΔIgG1-cre+/-YFP+ and
controls mice with regards to basal antibody levels.
We then examined whether ADAM10 deletion within GCs affected GC
maintenance and antigen-specific antibody production. ADAM10Δ/ΔIgG1-cre+/YFP+ mice and controls were immunized with 10µg of NP-KLH emulsified in
alum. The number of GC B cells, defined as B220+GL7+Fashi, 14 days postimmunization was quantified by flow cytometry. The percentage of GC B cells
was comparable between ADAM10Δ/ΔIgG1-cre+/-YFP+ and controls (Figure 31DE). Immunohistochemistry analysis also showed normal GCs, defined as clusters
of GL7+ within B cell follicle and normal splenic follicle architecture (Figure 31F).
Furthermore, TFH numbers were also normal (Figure 31G).
Interestingly, despite normal GC B cell numbers, antigen specific IgG1
was severely diminished (Figure 32B), while antigen-specific IgM levels were
comparable to control mice (Figure 32A). The normal IgM levels were not
surprising, as it has been reported that less that 2% of IgM+ cells undergo cre-
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mediated recombination128. These results demonstrate a defect in class-switched
antibody production.
Mice were also immunized with 100µg of NP-LPS, a T-independent
antigen. Surprisingly, antibody responses to these antigens were also severely
impaired (Figure 33). These results are rather unexpected because creexpression has been shown to occur in only 7% of IgG3-expressing cells128.
Further experiments will be needed in order to determine ADAM10-deletion in
IgG3-expressing cells in our system. Our results seem to suggest that the
majority of IgG3 secreting cells are ADAM10-deficient, as IgG3 production in
ADAM10Δ/ΔIgG1-cre+/-YFP+ mice is so dramatically impaired.

Plasma cell development in ADAM10Δ/ΔIgG1-cre+/-YFP+ mice
Given that ADAM10Δ/ΔIgG1-cre+/-YFP+ mice had impaired antibody
responses but normal GCs, we hypothesized that the defect resulted from
aberrant plasmablast and PC differentiation. CD138 is a marker for antibodysecreting plasmablast and PCs (B220int/lowCD138+ cells). Accordingly, we
immunized ADAM10Δ/ΔIgG1-cre+/-YFP+ and ADAM10+/+IgG1-cre+/-YFP+ mice with
10µg of NP-KLH and determined the percentage of cre-expressed plasmablast
and PCs (B220int/lowCD138+YFP+ cells) in the spleen (Figure 34B), peripheral
blood (Figure 34C) and bone marrow (Figure 34D)132. The gating protocol is
depicted in Figure 34A. Surprisingly, even though ADAM10Δ/ΔIgG1-cre+/-YFP+
mice had markedly impaired antigen-specific IgG1 responses, they had
plasmablast and PC percentages comparable to that of controls. Interestingly,
124

the number of IgG1 expressing cells in the spleen of ADAM10Δ/ΔIgG1-cre+/-YFP+
was significantly reduced (Figure 35). These results suggest that either ADAM10deletion impairs class switching to IgG1 or more likely, ADAM10-deletion leads to
impaired antibody production. Previous studies revealed a similar phenotype
when humoral responses were studied in B cell specific XBP-1-deficient mice135.
XBP-1 is a protein involved in ER-stressed and is required for antibodysecretion135. These data suggested that ADAM10 might regulate antibody
production by modulating XBP-1 expression in PCs.

Abnormal gene expression in plasma cells isolated from ADAM10Δ/ΔIgG1-cre+/YFP+
Given that the phenotype observed in ADAM10Δ/ΔIgG1-cre+/-YFP+ mice
resembled that of B cell specific XBP-1-deficient mice, we sought to determine if
XBP-1 levels were altered in PCs isolated from ADAM10Δ/ΔIgG1-cre+/-YFP+ mice.
Interestingly, Xbp-1 message levels were significantly reduced when compared
to controls (Figure 36C). Studies have demonstrated that Xbp-1 expression is
preceded by the downregulation of Bcl6 and the expression of Blimp-1 and
IRF4135. Thus, we next looked at the expression of these genes in the
ADAM10Δ/ΔIgG1-cre+/-YFP+ mice compared to controls. PC isolated from
ADAM10Δ/ΔIgG1-cre+/-YFP+ mice also showed a reduction in message levels for
Prdm1 (Figure 36A) (the gene encoding for Blmp-1) and Irf4 (Figure 36B).
Moreover, Bcl6 levels were significantly higher than in control PCs (Figure 36D).
Even more striking, while PC isolated from controls had ~60 fold more Prdm1
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message than Bcl-6, PCs isolated from ADAM10Δ/ΔIgG1-cre+/-YFP+ mice showed
only ~3 fold more Prdm1 than Bcl6 (Figure 36E). These results demonstrate that
ADAM10 is required for the proper downregulation of Bcl-6 and upregulation of
Prdm1, Irf4 and Xbp1, and thus for proper PC function and optimal humoral
responses.
Consistent with the gene expression results, flow cytometry analysis
revealed the presence of a B220lo/-CD138+Bcl6+ population in the spleens of
ADAM10Δ/ΔIgG1-cre+/- mice following immunization (Figure 37). These results
demonstrate that in the absence of ADAM10, Bcl6 is overexpressed at both the
message and protein level.
The results are summarized in Figure 38. In the absence of ADAM10,
there is a dysregulation in gene expression, leading to abnormal PC function and
impaired antibody production. Further studies are needed in order to determine
the underlying mechanisms connecting ADAM10 to Bcl6, Prdm1, Xbp1 and Irf4.
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Figure 31. ADAM10Δ/ΔIgG1-cre+/- mice have normal germinal center
formation.
(A-C) Naïve mice were bled and basal antibody levels were measured by ELISA.
(A) IgM, (B) IgG1 and (C) IgE. (D-G) Mice were immunized with NP-KLH
emulsified in alum and 14 days post-immunization GC formation and TFH cell
numbers were assessed by flow cytometry and immunohistochemistry. (D)
Representative dot plot (gated on B220+ cells). (E) Quantification of GC B cells,
representative of 5 mice from at least two independent studies. (F) Fourteen
days after NP-KLH immunization, spleens were isolated and sectioned. Sections
stained for GL7 (green) and IgD (red). (G) Quantification of TFH cells,
representative of 5 mice from at least two independent studies
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Figure 32. ADAM10Δ/ΔIgG1-cre+/- mice show impaired antibody responses to
T-dependent antigens.
ADAM10Δ/ΔIgG1-cre+/- (●) and controls (○) were immunized with NP-KLH
emulsified in alum. At the indicated times, serum samples were collected and
NP-specific (A) IgM and (B) IgG1 were measured by capture ELISA. Bars
represent the mean ± SE of 5-9 mice per group (*p<0.05). Data represent results
obtained in at least two independent experiments.
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Figure 33. ADAM10Δ/ΔIgG1-cre+/- mice show impaired antibody responses to
T-independent antigens.
ADAM10Δ/ΔIgG1-cre+/- (●) and controls (○) were immunized with NP-LPS. At the
indicated times, serum samples were collected and NP-specific (A) IgG3 and (B)
IgG1 were measured by capture ELISA. Bars represent the mean ± SE of 5-9
mice per group (*p<0.05, **p<0.01). Data represent results obtained in at least
two independent experiments.
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Figure 34. ADAM10Δ/ΔIgG1-cre+/- mice have normal plasma cell percentages.
ADAM10Δ/ΔIgG1-cre+/-YFP+ and

controls

were

immunized

with

NP-KLH

emulsified in alum. Twenty-one days following immunization, tissues were
harvested and PC numbers were analyzed. (A) Representative FACS staining of
ADAM10Δ/ΔIgG1-cre+/-YFP+ (bottom) and controls (top).. Quantified results from
(B) spleen, (C) peripheral blood and (D) bone marrow. Bars represent the mean
± SE of 4-5 mice per group. Data represent results obtained in at least two
independent experiments.
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Figure 35. ADAM10Δ/ΔIgG1-cre+/- mice have decreased numbers of IgG1+
cells.
ADAM10Δ/ΔIgG1-cre+/- and controls were immunized with NP-KLH emulsified in
alum. Fourteen days following immunization, spleens were harvested and the
percentage of B220+IgDloIgG1+ was quantified by flow cytometry. Quantified
results are depicted. Bars represent the mean ± SE of 4-5 mice per group. Data
represent results obtained in at least two independent experiments. (*p<0.05)
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Figure 36. Plasma Cells isolated from ADAM10Δ/ΔIgG1-cre+/- have altered
gene expression.
ADAM10Δ/ΔIgG1-cre+/- and controls were immunized with NP-KLH emulsified in
alum. Twenty-one days following immunization, splenic PCs were isolated via
magnetic bead isolation. mRNA was isolated and (A) Prdm1, (B) Irf4, (C) Xbp1
and (D) Bcl6 message levels were determined by qPCR. (E) The ratio of Prdm1
to Bcl6 was calculated. Bars represent the mean ± SE of 3 independent studies;
cells from 3 mice from each genotype were pooled in each study. (*p<0.05,
**p<0.01, ***p<0.001).
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Figure 37. Plasma cells isolated from ADAM10Δ/ΔIgG1-cre+/- mice express
Bcl6 protein
ADAM10Δ/ΔIgG1-cre+/- and controls were immunized with NP-KLH emulsified in
alum. Twenty-one days following immunization, splenic plasma cells were
analyzed by Bcl6 protein expression via flow cytometry. (A) CD138+B220lo/- B
cells were gated and analyzed for either (B) non-specific staining (isotype) or (C)
Bcl6 staining. (D) Quantified results are depicted. Bars represent the mean ± SE
of 4-5 mice. (**p<0.01).

139

140

Figure 38. Proposed Model: Adam10 Regulations Of Plasma Cell Function
Wild type plasma cells express much higher levels of Blimp-1, IRF4 and XBP-1
that at previous developmental stages, while Bcl6 is repressed. This allows for
antibody secretion. In the case of ADAM10IΔ/ΔIgG1-cre+/- mice, Bcl6 levels are
much higher than seen in wild type. Moreover, Blimp-1, IRF4 and XBP-1
expression are decreased, leading to impaired antibody secretion
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3.5 Discussion

Members of the ADAM family regulate a wide range of functions, including
cell migration, proliferation and adhesion212. ADAM10, in particular, has been
recently shown to be critical for lymphocyte development through initiation of the
canonical Notch signaling pathway (see Figure 3)24,174. Here we report that
ADAM10 is dispensable for early B cell development within the bone marrow.
However, deletion of ADAM10 from all peripheral B cells or in post-switch B cells
leads to severe impairments in antibody responses. When ADAM10 was deleted
from all peripheral B cells a decrease in antigen specific IgG production was
seen both with respect to serum levels and IgG ASCs, indicating that PC
differentiation is influenced. Cells producing high affinity antibodies were
particularly affected, consistent with defects in GC reactions and markedly
repressed FDC-reticula. Moreover, changes in lymphoid architecture were also
observed. On the other hand, when ADAM10 was deleted in post-switch B cells,
GC formation and lymphoid architecture were not impaired. Despite normal
architecture, however, antibody production was still affected, likely due to
abnormal gene expression in ADAM10-deficient PCs. Consistent with this
hypothesis, PCs isolated from ADAM10Δ/ΔIgG1-cre+/- showed decreased
expression of genes that facilitate plasma cell differentiation and function and
increased expression of Bcl6, an inhibitor of PC differentiation.
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ADAM10 is dispensable for early B cell development
ADAM10 is critical for the development of T cells due to its role in Notch1
signaling. Studies revealed that ADAM10-deficient common lymphoid progenitor
cells (CLPs) failed to develop into T cells, while B cell development was not
impaired174. We decided to carry out similar experiments in order to assess
whether ADAM10 is needed for early B cell development by knocking out
ADAM10 in a B cell specific manner at the pro-/pre-B cell stage. Our results
demonstrate that ADAM10 is dispensable for immature B cell development.
Consistent with this finding, it has been recently reported that the use of an
ADAM10 inhibitor in an in vitro system of hematopoiesis did not affect B cell
development193.

Impaired Notch signaling and increased CD23 expression are not likely to
contribute to the phenotype observed in ADAM10B-/- mice
As previously mentioned, here we demonstrate that ADAM10 is essential
for mature B cell function. ADAM10B-/- mice showed severely impaired humoral
responses and alterations in lymphoid tissue architecture. In order to determine
the mechanism underlying the observed phenotype, we investigated the role of
two well described B cell expressed ADAM10 substrates: Notch and
CD2324,174,182. The role of Notch signaling in mature B cell function is
controversial. While some studies have clearly shown a role for Notch in antibody
production, others failed to identify such a role177,180. In order to assess the role
of Notch signaling in lymphoid tissue organization and antibody production, we
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expressed N2ICD transgene in a B cell specific manner, by conditionally
expressing N2ICD in a cre-dependent manner, under the control of CD19-cre.
We have demonstrated that restoration of Notch2 signaling in ADAM10B-/- mice is
not sufficient to rescue antibody production or GC formation. Studies have shown
that N2ICD and N1ICD have redundant functions. Our results, therefore, suggest
that the phenotype observed in ADAM10B-/- mice is not dependent Notch1 nor
Notch2 signaling213, however, whether impaired Notch1 signaling contributes to
the phenotype observed in ADAM10B-/- mice should be formally studied.
Another feature of ADAM10-deficient B cells is decreased expression of
CD2124. Since Notch signaling enhances CD21 expression, the finding that the
introduction of the N2ICD transgene failed to rescue antibody production and GC
formation in ADAM10B-/- mice also suggests that CD21 is not involved in the
ADAM10B-/- phenotype, N2ICD transgene expression led to increase CD21
expression. In addition, unlike CD21/CD35-/- mice, ADAM10B-/- mice had impaired
affinity maturation and failed to mount antibody responses comparable to
controls following immunization even at large antigen dosages (i.e. 1mg)214.
CD23, also known as the low affinity IgE receptor, is another B cell
expressed ADAM10 substrate182. We have recently demonstrated that CD23
surface expression is significantly enhanced after deletion of ADAM10 in B
cells24. Defects observed in ADAM10B-/- could result from CD23 overexpression.
Previous studies with CD23Tg mice, however, demonstrated that elevated CD23
levels resulted in inhibition of IgE and IgG1 production, while other classes were
not significantly affected. On the other hand, in ADAM10B-/- mice, the production
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of all classes of IgG was impaired. Moreover, when immunized with NP-KLH,
CD23Tg mice had Ig levels comparable to that of WT. In contrast, ADAM10B-/mice showed diminished levels of both low and high affinity anti-NP antibodies.
These results suggest that elevated CD23 levels do not explain the phenotype of
ADAM10B-/- mice. However, in order to demonstrate that the phenotype observed
in ADAM10B-/- mice is CD23-independent, we are generating mice that lack both
CD23 and B cell expressed ADAM10 by mating CD23-/- mice and ADAM10B-/mice215 It is possible that another B cell expressed ADAM10 substrate is
responsible for the phenotype observed in ADAM10B-/- mice.

ADAM10 is important for B cell follicle formation and maintenance of lymphoid
architecture
In lymphoid organs, the correct positioning of B cells and T cells as well as
the migration during an immune response are critical for adequate interaction
between them28. As previously mentioned, interactions between cognate B cells
and T cells play are essential for adequate responses to T-dependent antigens.
Our results demonstrate that while B cell expressed ADAM10 is dispensable for
B cell homing during LN and spleen development, ADAM10 is critical for the
maintenance of B cell and T cell positioning subsequent to immune stimulation.
However, ADAM10 also is needed for normal B cell follicle formation, as a
thinning of B cell follicular areas was observed in LN of ADAM10B-/- mice. The
aberrant B cell follicle structure is accompanied with excessive collagen
deposition and a relative increase in FRCs.
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TNF-α is another ADAM10 substrate and it has been implicated in the
formation of primary B cell follicles and GCs185. Unlike ADAM10B-/- mice, TNF-α
deficient mice have a more dramatic disruption of splenic architecture prior to
immunization14. However, TNF-α deficient or TNF-α receptor-deficient mice also
had normal B cell homing but defective B cell follicle formation216,217. Moreover,
studies have demonstrated that secreted TNF-α is important for lymph node
architecture, while membrane bound TNF-α is sufficient to support normal splenic
architecture development217. Furthermore, B cells were found to be an essential
source of secreted TNF-α during LN development202. Interestingly, despite
normal TNF-α expression, ADAM10-deficient B cells secreted significantly less
TNF-α than WT B cells following in vitro stimulation. These results suggest that
the abnormal appearance of B cell follicles in LN of ADAM10B-/- is likely due to a
defect in B cell TNF-α shedding.
Lymphotoxin-alpha (LT) is another TNF-α family member that is involved
in lymphoid architecture. The phenotype of ADAM10B-/- mice is also different to
that seen with LT-deficient mice, however, as LT-deficient mice lack peripheral
LN and have severely disrupted splenic architecture12. Interestingly, LT has been
shown to be important for the maintenance of splenic architecture in adult
mice218. These results suggest that during an active immunization, lymphotoxin
production by ADAM10-deficient B cells might be impaired.
CCL21, CCL19 and CXCL13 have been shown to play a key role in
inducing and maintaining normal cellular compartments18. Draining LNs from
ADAM10B-/- mice showed increased CCL21 mRNA expression. This increase in
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CCL21 was also confirmed at the protein level by immunohistochemistry.
Interestingly, ADAM10B-/- mice had a larger area of CCL21 staining, consistent
with the aberrant T cell localization seen in draining LNs. The cells responsible
for CCL21 production in LN are fibroblastic reticular cells (FRCs)219,220. Despite
having normal CCL21 mRNA levels, compared to WT LN, FRCs made up a
larger percentage of the stromal cells present in LN of ADAM10B-/- mice. Recent
studies have demonstrated that following immunization, FRCs expand in a B cell
dependent manner. Therefore, it is likely that due to the basal increase in FRCs
observed in ADAM10B-/- LN, an increase in CCL21 is also apparent. FRC
numbers following immunization should be studied in ADAM10B-/- mice.
FDCs are important for GC development, CSR, SHM and affinity
maturation as well as induction of recall responses105,221-225. FDCs also secrete
CXCL13 and are thus important for recruitment of CXCR5-expressing B cells and
T cells into the follicle226. Moreover, they are required for the maintenance of B
cell and T cell zones28. The loss of B cell and T cell segregation and the lack of
GCs in the draining secondary lymphoid tissues of ADAM10B-/- mice are thus
consistent with a decreased number of FDC networks. The fact that CXCL13
mRNA levels were not altered, despite the lack of FDCs was surprising.
However, recent published reports have also noted that CXCL13 expression is
not affected by FDC depletion227. Together, these results challenge that idea that
FDCs are the main producer of CXCL13.
Studies have demonstrated that FDCs are required for GC B selection
within GCs. If GC B cells fail to interact with immune complexes displayed in the
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surface of FDCs, the cells will undergo apoptosis96. FDC-mediated GC B cell
selection is consistent with the finding that in the absence of FDCs GC B cell
numbers are diminished, as observed in ADAM10B-/- mice.
The changes in architecture correlate with the decrease in TFH cells. TFH
cells provide B cell help and are thus essential for PC differentiation, memory cell
generation and affinity maturation228. A decrease in the number of TFH cells leads
to decreased B cells help, thus leading to diminished isotype switching.

ADAM10 might regulate B cell activation
Decreased B cell activation is consistent with the phenotype we observe in
the ADAM10B-/- mice and it is the likely to contribute to the defect in humoral
responses. When B cells were stimulated with LPS, ADAM10-deficient B cells
showed impaired antibody productions. However, when ADAM10-deficient B
cells were stimulated with anti-CD40 and IL-4, antibody production was not
affected. These results suggest that ADAM10 might be involved in B cell
activation, but its involvement might dependent on the specific stimulation. B cell
activation in vitro occurs very differently from antigen-specific in vivo responses,
thus making it difficult to correlate in vitro and in vivo findings. Discrepancies
between in vivo and in vitro results might relate to differences in short lived and
long-lived plasma cells. Moreover, in vitro differentiation assays often lead to a
heterogenous population of cells, displaying different degrees of activation thus
making the study of B cell responses difficult. Furthermore, in vitro activation
might not precisely reflect in vivo stimulation 229.
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ADAM10 is required for plasma cell function
The changes in architecture observed in ADAM10B-/- mice did not allow us
to discern whether ADAM10 is important for antibody production or if the defects
in antibody responses were secondary to architectural changes. Here we
demonstrate that mice with ADAM10–deletion in class-switched B cells
(ADAM10Δ/ΔIgG1-cre+/- mice) have normal GC formation and show no changes in
lymphoid architecture. These mice, however, showed defective antibody
responses to T-dependent and T-independent antigens. Furthermore, we show
that despite having normal PC percentages, defined as CD138-expressing cells,
expression levels of transcription factors important for PC development, Prdm1,
xbp1 and Irf4 were altered, while housekeeping gene levels remained
unchanged.

In addition, the GC transcription factor Bcl6 was not properly

downregulated in ADAM10Δ/ΔIgG1cre+/- mice. These results demonstrate that
ADAM10 is required for proper downregulation of Bcl6, upregulation of Prdm1,
Irf4

and

Xbp1.

Subsequently,

antibody

secretion

is

abnormal

in

ADAM10fl/flIgG1cre+/- mice. Thus ADAM10 is important for proper PC function in
vivo. Interestingly, when gene expression was assessed in in vitro activated B
cells, gene expression varied from sample to sample, thus making it difficult to
discern differences between WT and ADAM10-deficient B cells. These results
are consistent with the concept that in vitro activation leads to heterogenous
populations of cells229.
The transcription factor Bcl6 is necessary for GC formation and B cell
proliferation. While it is well established that Bcl6 must be downregulated for PC
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differentiation to occur230, the factors mediating its downregulation are not fully
understood. It has been previously demonstrated that STAT3, downstream of IL21, can trigger Blimp-1 expression by competing with Bcl6 for DNA binding
sites109. Moreover, it has been proposed that B-cell receptor (BCR) and CD40
signaling lead to Bcl-6 degradation110. Recent studies demonstrated that ectopic
STAT3 signaling could induce Blimp-1 expression even in the presence of high
Bcl-6 levels; however, PC differentiation did not proceed until Bcl6 levels were
reduced109. Here we demonstrate that ADAM10 is essential for Bcl6
downregulation at least in vitro and that ADAM10 deficiency leads to impaired
antibody responses.
Studies have demonstrated that IL-6 signaling can induce Bcl6
expression99,103. In the context of a GC, IL-6 is produced by activated FDCs and
promotes SHM and affinity maturation105. Given that ADAM10 is responsible for
the cleavage of the IL-6 receptor (IL-6R)183, one could speculate that increased
IL-6R expression could lead to increased IL-6 signaling, thus leading to Bcl6
overexpression.
Along with defective Bcl-6 downregulation observed in PCs isolated from
ADAM10B-/- mice, ADAM10 deletion also resulted in decreased levels of Prdm1,
the gene encoding for Blimp-1, Irf4 and Xbp-1. Blimp-1 and IRF4 lead to cell
cycle arrest and promote PC development133, while XBP-1 is required to for
endoplasmic reticulum (ER) expansion and immunoglobulin production and
secretion134 Moreover, Blimp-1 and IRF4 permit XPB1 expression132,134.
Furthermore, it has been very well documented that Bcl-6 can inhibit Blimp-171. It
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is therefore possible that ADAM10 is involved in a pathway that controls both
Blimp-1 and IRF4 expression, and decreased Blimp-1 and IRF4 then leads to
decreased XBP-1 expression.
As demonstrated in this study, humoral responses were severely impaired
in ADAMΔ/ΔIgG1-cre+/- mice. Surprisingly, the number of PCs was comparable
between ADAMΔ/ΔIgG1-cre+/- mice and controls. Previous studies revealed a
similar phenotype when humoral responses were assessed in B cell specific
XBP-1-deficient mice. As previously mentioned, XBP-1 is a transcription factor
involved in ER-stressed and is required for antibody-secretion. PCs isolated from
ADAMΔ/ΔIgG1-cre+/- mice had decreased XBP-1 message levels, suggesting that
the phenotype observed in ADAMΔ/ΔIgG1-cre+/- mice is partly due to decrease
XBP-1 expression and impaired antibody secretion.
As previously mentioned, ADAM10 is critical for Notch1 and Notch2
cleavage and the initiation of the canonical Notch signaling pathway (see Figure
2)24,174. The role of Notch signaling in GC formation and PC differentiation,
however, remains controversial. In vivo studies of B cell specific RBP-Jk-deficient
mice, a key mediator of Notch signaling, failed to reveal a defect in antibody
production180. Consistent with this finding, a recently published report
demonstrated that B cell-specific Notch2-deficient mice have normal GC
formation231. Moreover, mice with constitutively active Notch2 intracellular
domain (Notch2-ICD) showed defective antibody responses to T-dependent and
T-independent antigens and impaired GC formation232. On the other hand, in
vitro studies have demonstrated that Notch signaling enhances B cell activation
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and supports B cell survival178. Moreover, recent studies have shown that Notch
signaling synergizes with B-cell receptor (BCR) and CD40 signaling to enhance
murine B cell activation177. Further studies will be needed to elucidate the role of
Notch1 and Notch2 in PC differentiation and function and to determine whether
the phenotype observed in ADAMΔ/ΔIgG1-cre+/- mice results from defective Notch
signaling.

ADAM10: Not just a sheddase
Cleavage of membrane-bound proteins, such as Notch receptors, is not
the only way that ADAM10 is capable of modulating gene expression. Recent
experiments have demonstrated that ADAM10 not only mediates receptor
intramembrane proteolysis (RIP), but it is also subject to RIP. ADAM9 and
ADAM15 have been identified as the proteases responsible for releasing the
ADAM10 ectodomain, while gamma-secretase mediates the release of the
ADAM10 intracellular domain (ICD). ADAM10-ICD then translocates to the
nucleus and modulates gene expression162. Studies have demonstrated that
nuclear ADAM10 can interact with androgen receptors and act like a transcription
factor233. It is thus possible that ADAM10 regulates Bcl-6 expression and PC
function, not by shedding of membrane proteins but through its involvement in
gene regulation. These recent findings really expand the potential roles for
ADAM10 in regulating cellular functions. ADAM10-ICD regulation of gene
expression will require further study.
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Several reports have demonstrated that ADAM10 and a few of its
substrates are present in exosomes, which are small secreted vesicles159,160. It is
possible that ADAM10-expressing B cell secreted exosomes play a role in
regulating GC formation and PC differentiation. However, further experiments are
necessary to determine the mechanism by which B cell expressed ADAM10
controls humoral responses, lymph node development and the maintenance of
lymphoid architecture.

Conclusions and future directions
In conclusion, while ADAM10 is dispensable for early B cell development,
our studies have demonstrated that ADAM10 is critical for the maintenance of
splenic and lymph node architecture during active immune responses. ADAM10deletion from all peripheral B cells (ADAM10B-/- mice) led to decreased numbers
of TFH cells, leading to diminished T cell help and impaired GC formation, affinity
maturation and CSR. On the other hand, deletion of ADAM10 in GC B cells does
not

impair

GC

formation.

However,

despite

normal

PC

numbers,

ADAM10Δ/ΔIgG1-cre+/-YFP+ mice showed impaired antibody responses to Tdependent and T-independent antigens. Gene expression analysis demonstrated
that PCs isolated from ADAM10Δ/ΔIgG1-cre+/-YFP+ mice expressed lower levels
of Prdm-1, Irf4 and Xbp-1 and expressed 3-fold more Bcl6 than WT counterparts.
These results thus demonstrate that ADAM10 is important for PC function,
independently of the changes in architecture observed in ADAM10B-/- mice.
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While the studies described here have really expanded our knowledge of
the role of B-cell expressed ADAM10 in B cell biology and the development and
maintenance of lymphoid tissue architecture, there are many questions that have
not been addressed. While we know that ADAM10-mediates B cell follicle
formation, likely through TNF-α shedding, this has not been proven. Mixed bone
marrow chimera with WT and ADAM10B-/- BM and ADAM10B-/- and TNF-α-/- BM
will be used to determine whether impaired TNF-α release in ADAM10B-/- mice
results in impaired B cell follicle formation. While LN from WT/ADAM10B-/- mice
should be normal because WT B cells can provide enough TNF-α-/- to allow for
normal B cell follicle formation, we would expect that LN from ADAM10B-/-/ TNF-α/-

would have impaired follicle formation, as ADAM10-deficient B cells nor TNF-α-

deficient B cells could release TNF-α and support B cell follicle formation.
The work described here focuses on the role of ADAM10 in conventional
or B2 B cells. Another B cell subset are B1 B cells. B1 B cells are located mostly
within the peritoneal cavity and produce natural antibodies. Natural antibodies
are antibodies that recognize very common bacterial antigens, such as
phosphorycholine234. It would be interesting to determine whether ADAM10 also
plays a role in B1 B cell function.
Secondary lymphoid organs are positioned such that they facilitate
immune responses to foreign antigens. In states of chronic inflammation,
lymphoid cell aggregates that have a similar organization to secondary lymphoid
organs can develop; these structures are known as tertiary lymphoid structures.
These structures have been described in patients with atherosclerosis and
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rheumatoid arthritis28. Tertiary lymphoid organs have organized B cell
compartments, which often include GCs, and T cell compartments, in which
antigen-presenting cells can be detected. When tertiary organs develop at sites
where autoantigens are continuously being presented, they may lead to
unnecessary tissue destruction by facilitating the activation of autoreactive
lymphocytes28. Our results demonstrate that ADAM10 is critical for the structural
maintenance of secondary lymphoid organs during active immune responses and
thus, suggest a role for ADAM10 in the maintenance of tertiary lymphoid organs.
Further experiments are needed to determine whether ADAM10 plays a role in
tertiary lymphoid tissue formation and whether ADAM10 is a potential therapeutic
target for the treatment of diseases involving tertiary lymphoid tissues. As
complete loss of ADAM10 is lethal in utero158, systemic ADAM10 blockade could
have severe side effects. We have recently shown that intranasal administration
of ADAM10 inhibitors reduced symptomology in the mouse asthma model
without causing any obvious deleterious effects235. Thus, it may be possible to
use local ADAM10 inhibition in some B-cell mediated autoimmune scenarios to
decrease autoimmune symptoms. ADAM10 inhibition is not only likely to affect
tertiary lymphoid structure, but also to affect autoantibody production within these
tissues.
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CHAPTER 4: FYN IS REQUIRED FOR OPTIMAL GERMINAL CENTER
FORMATION AND ANTIBODY PRODUCTION

4.1 Introduction to Fyn
The gene SH2D1A encodes for SLAM-associated protein (SAP).
Mutations in this gene resulting in SAP-deficiency or SAP protein destabilization
cause X-linked lymphoproliferative disease (XLP). Patients with XLP often have
difficulties clearing infections, such as EBV, measles virus and Neisseria
meningitides. They also show progressive hypogammaglobulinemia and
increased incidence of B cell lymphomas236.
SAP interacts with SLAM (CD150) through binding to the cytoplasmic tail.
Subsequently, SAP recruits the Src protein kinase Fyn. Studies have
demonstrated that SAP directly binds Fyn via an unconventional SH3 domainbinding surface237-239. This binding requires arginine 78 residue (R78) on the SAP
protein237,239. Recruitment of Fyn leads to the phosphorylation of tyrosine
residues in the cytoplasmic domain of SLAM. This phosphorylation event
generates docking sites for several proteins and initiates signaling cascades240.
Fyn is a member of the Src protein tyrosine kinase. Fyn is widely
expressed in many cell types, including lymphocytes241. Fyn has been shown to
interact with both the B cell and T cell receptor (BCR and TCR,
respectively)242,243. While Fyn-deletion did not impair the development of
immature T cells and B cells, TCR signaling was altered in mature T cells143,244.
Recent studies have suggested that SAP regulates NKT cell development
in a Fyn-dependent and independent manner. Experiments demonstrated that
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SAP-deficient mice have a reduction in the number of NKT cells. Mice expressing
SAP R78A, a mutant SAP that is unable to bind Fyn (SAPR78A mice), still had
diminished NKT cell numbers, but the defect in NKT cell development was not as
pronounced as that observed in SAP-deficient mice245.
Another feature of SAP-deficient mice is a severe impairment in GC
development accompanied with impaired generation of memory B cells and longlived plasma cells246. Through the use of conditional SAP-knockouts and
adoptive transfer approaches, two groups demonstrated that T cell SAP
expression was important for humoral responses67,246. B cell specific SAP
deficiency did not impair antigen-specific immunoglobulin production or GC
formation. Indeed, GC B cell numbers were enhanced in SAPΔ/ΔCD19-cre+
mice67. Further studies demonstrated that SAP was dispensable for the
interaction between T cells and DCs. However, SAP-deficient T cells were shown
to be unable to make stable interactions with cognate B cells66. It was later
determined that these defects in stable B-T interactions resulted in impaired TFH
development and diminished T cell help247,248.
Interestingly, it was demonstrated that SAP regulates TFH development in
a Fyn-independent manner, as evidenced by the fact that SAPR78A mice had
normal TFH and GC B cell numbers247,249. Experiments with Fyn-deficient mice
(Fyn-KO) demonstrated that they are able to form GCs. The authors of these
studies concluded that Fyn is dispensable for GC formation, however, how GC B
cell numbers compare to that of wild type cannot be deduce from thes studies
being that Fyn-KO mice are in a B6.129 background and no B6.129 wild type
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mice were studied in those experiments249.
The SAP-Fyn axis has also been demonstrated to mediate many aspects
of T cell biology. Studies have demonstrated that both Fyn and SAP are
important for Th2 differentiation. Studies have demonstrated that Fyn-KO and
SAP-deficient T cells produced little to no IL-4 following anti-CD3 and anti-CD28
stimulation250. Moreover, it has been reported that TFH cells present within GCs
(GC TFH cells) depend on the SAP-Fyn axis for IL-4 production248.
The data regarding the role of Fyn in cytokine production and Th2 cell
differentiation is conflicting. While some have reported that Fyn-KO mice are
impaired in IL-4 production250, other have reported that Fyn-KO T cells
preferentially differentiate into Th2 cells251. Furthermore, it was reported that FynKO T cells produced increased levels of IL-4 but reduced IFN-γ levels251,252.
Consistent with these findings, Fyn-KO T cells showed exaggerated responses in
a mouse model of allergic airway inflammation253. Interestingly, while naïve Fyndeficient mice had reduced IgE levels, immunized mice had comparable IgE
levels to that of WT253. Others have demonstrated that Fyn-KO mice have
elevated IgE following immunization254. It is possible that Fyn is involved in the
secretion of both IL-4 and IFN-γ and which cytokine is more impaired might
depend on the situation.
While much of the research regarding Fyn in lymphocyte biology has
focused on T cells, Fyn is also expressed in B cells255. As previously mentioned,
Fyn interacts with the BCR. Moreover, Fyn interacts with the BCR co-receptor
CD19 (See Chapter 1)256. Interestingly, Fyn-KO B cells showed only a mild
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impairment in BCR signaling257. Moreover, humoral responses to T-dependent
antigens 7 days following immunization were lowered in Fyn-KO mice, although
the difference was not statistically significant, likely due to the fact that only few
mice per group were used in these experiments257. On the other hand, Fyn-KO
mice showed a marked decrease in Ig subsequent to T-independent
antigens244,258.
Fyn has also been associated with IL-5 receptor142,257. IL-5 is a pleotropic
cytokine. With regard to B cells, IL-5 signaling has been shown to contribute to
induce IgA production by antigen-primed B cells and LPS stimulated B
cells259,260. Moreover, in the presence of IL-4, IL-5 can induce IgG1 and IgE
secretion. It has been demonstrated that in combination with IL-4, IL-5 leads to
the accumulation of γ1 and ε chain transcripts261. Fyn-KO B cells have been
shown to have impaired IL-5 signaling142.
Fyn has also been shown to associate with CD23, the low affinity IgE
receptor, also known as FcεRII. Studies of CD23-deficient and CD23-transgenic
mice demonstrated that CD23 is the natural regulator of IgE production262. The
role of Fyn in CD23 signaling and IgE production should be carefully assessed.
While a role for Fyn in cytokine production and antibody responses has
been reported, the role of Fyn in humoral responses remains controversial. We
thus decided to examine humoral responses in Fyn-KO mice. Our results
demonstrate that Fyn-KO mice have significantly low basal IgG1 and IgG2a.
Additionally, these mice displayed delayed kinetics in the production of NPspecific IgG1 and IgG2b, and significantly low NP-specific IgG2a after a T-
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dependent immunization protocol. Defects in antibody production correlated with
significantly reduced numbers of GC B cells, TFH cells and spleen plasma cells.
Moreover, Fyn-KO B cells showed decreased antibody production following in
vitro activation. Our results thus demonstrate that Fyn-mediated signaling is
necessary for optimal humoral responses.

4.2 Results
Fyn deficient animals have low basal IgG1 and IgG2a
In order to better understand Fyn’s role in humoral immunity, we analyzed
antibody levels in the serum of naïve Fyn-KO and WT B6.129 mice. Compared to
WT, Fyn-KO mice had normal IgM levels and IgG2b, but significantly decreased
basal IgG1 levels and IgG2a (Figure 39). IgE levels were below the levels of
detection in both WT and Fyn-KO mice. These findings implicated Fyn in
antibody production.

Fyn kinase deficiency affects antigen-specific antibody production
To directly assess antigen-specific antibody production, Fyn-KO and WT
mice were immunize i.p. with NP-KLH in alum and the generation of NP-specific
antibodies was monitored by ELISA. Surprisingly, while Fyn-KO mice showed
normal antigen-specific IgM responses (Figure 40A), they had a severely
impaired NP-specific IgG2a response (Figure 40C). With regards to NP-specific
IgG1 and IgG2b, Fyn-KO mice demonstrated a delayed in Ig production, but had
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normal levels of NP-specific Ig four weeks following immunization (Figure
40B,D), suggesting abnormal antibody production kinetics.

Splenic PC numbers are reduced in Fyn deficient mice
Given the diminished antibody response observed in Fyn-KO mice, we
hypothesized that CSR or PC development were impaired in these mice. In order
to determine whether PC generation was abnormal in Fyn-KO mice, we
immunized mice with NP-KLH and determined the number of PC by flow
cytometry 14 days post-immunization. Consistent with the defects in antibody
production, Fyn-KO mice showed decreased in the proportion of splenic PCs
(CD138+B220lo/- cells) (Figure 41).

GC formation is impaired in Fyn deficient mice
A large portion of PCs in response to T-dependent antigens are derived
from GCs, we therefore assessed GC formation in Fyn-KO mice. GC B cells,
defined as B220+GL7+Fashi were enumerated by flow cytometry 14 days
following NP-KLH immunization. Our results demonstrate that 14 days postimmunization, Fyn-KO mice showed significantly decreased levels of GC B cells
compared to WT controls (Figure 42).

TFH formation is impaired in Fyn deficient mice
TFH cells provide B cell help via CD40L, IL-21 and IL-4. They play a key
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role in GC B cells survival, affinity maturation, and plasma cell differentiation. TFH
cells are characterized by high expression of CXCR5 and programmed death-1
(PD-1). We therefore examined whether the decreased number on GC B cells
was accompanied with decrease TFH number. TFH cells were enumerated by flow
cytometry 14 days following NP-KLH immunization. Interestingly, TFH numbers
were significantly reduced in Fyn-KO mice (Figure 43). Our data reveal a novel
role of Fyn kinase. Our experiments demonstrate that Fyn is required for optimal
GC B cell and TFH cell development or maintenance.

Fyn kinase is required for B cell antibody production in vitro
In order to determine whether Fyn-deletion affected antibody production in
a B cell intrinsic manner, WT and Fyn-KO B cells were stimulated with anti-CD40
and IL-4. Proliferation and antibody production were then measured. Compared
to WT B cells, Fyn-KO B cells produced significantly lower amounts of IgG1 and
IgE (Figure 44A,B). These results demonstrate that, at least in vitro, Fyn-KOB
cells have impaired activation. Interestingly, Fyn-KO B cells showed no alteration
in proliferation (Figure 44C). It is likely that the phenotype observed in vivo
results from both a B cell-intrinsic defect and impaired cytokine production.
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Figure 39. Fyn deficient mice have impaired humoral responses.
Serum (A) IgM, (B) IgG1, (C) IgG2a and (D)IgG2b were measured by ELISA
from non-manipulated 8-12 week old mice. Bars represent the mean ± SE of 10
mice per group (***p<0.001). Data represent results obtained in at least two
independent experiments.
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Figure 40. Fyn-KO mice have impaired humoral responses to T-dependent
antigens
Fyn-KO mice and WT controls were immunized with 10µg NP-KLH emulsified in
alum. At the indicated times, serum samples were collected and NP-specific (A)
IgM, (B) IgG1, (C) IgG2a and (D) IgG2b antibody titers were determined by
ELISA. Bars represent the mean ± SE of 5-9 mice per group (*p < 0.05, **p<0.01,
***p<0.001). Data represent results obtained in at least two independent
experiments.
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Figure 41. Fyn-KO mice have reduced plasma cell percentages.
Fyn-KO and WT mice were immunized with NP-KLH emulsified in alum. Twentyone days following immunization, spleens were harvested and PC numbers were
analyzed. (A) Representative FACS staining. (B) Quantified results from spleen.
Bars represent the mean ± SE of 6 mice per group. Data represent results
obtained in at least two independent experiments. (p<0.01)
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Figure 42. Fyn deficient mice have impaired germinal center formation.
Mice were immunized with NP-KLH emulsified in alum and 14 days postimmunization GC formation was assessed by flow cytometry. (A) Representative
dot plot (gated on B220+ cells). (B) Quantification of GC B cells. Bars represent
the mean ± SE of 6 mice per group. Data represent results obtained in at least
two independent experiments. (p<0.001)
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Figure 43. Fyn deficient mice have reduced TFH numbers
Mice were immunized with NP-KLH emulsified in alum and 14 days postimmunization TFH cell numbers were assessed by flow cytometry. (A)
Representative dot plot (gated on CD4+ cells) (B) Quantification of TFH cells. Bars
represent the mean ± SE of 6 mice per group. Data represent results obtained in
at least two independent experiments. (p<0.001).
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Figure 44. Fyn deficient B cells produce reduced antibody levels despite
normal proliferation following in vitro stimulation.
B cells were isolated and cultured with IL-4 and anti-CD40L. Eight days following
stimulation, supernatant were harvest and analyzed for (A) IgG1 and (B) IgE by
ELISA. (C) Three days following challenge, tritiated thymidine was added to cells.
Cells were incubated for 24 hours and then harvested. Thymidine incorporation
was then measured. Experiment has been performed three times with similar
results. (*p<0.05, **p<0.01).
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4.3 Discussion
Fyn is a member of the Src protein tyrosine kinase family. Previous work
has demonstrated that Fyn-deficient T cells have impaired cytokine production
that is accompanied by impaired antibody production. However, several
conflicting reports have been published. Here we demonstrate that Fyn-KO mice
showed decreased basal IgG1 and IgG2a levels. Additionally, following
immunization, these mice had altered kinetics regarding NP-specific IgG1 and
IgG2b productions. Moreover, Fyn-deficient mice displayed a dramatic defect in
NP-specific IgG2a production. These defects correlated with significantly reduced
numbers of GC B cells, TFH cells and spleen PCs. Moreover, Fyn-KO B cells
showed decreased antibody production following in vitro activation. Our results
thus demonstrate that Fyn-mediated signaling is necessary for optimal humoral
responses.
The role of Fyn in GC formation has been previously assessed. Cannons,
et al. immunized C57B6 WT, 129 WT mice and Fyn-KO mice in a mixed
C57B6.129 background. In these experiments, C57B6 WT mice had fewer GC B
cells than 129 WT mice, while Fyn-KO mice had GC B cell numbers comparable
to C57B6 WT mice. Based on these results, the authors concluded that Fyn was
dispensable for GC formation249. However, it is difficult to draw conclusions form
these experiments given that the mice were not background matched. Our
results demonstrate that Fyn is important for GC B cell differentiation.
It has been previously reported that Fyn is involved in IL-4 secretion.
While some report that Fyn-deficient T cells are unable to secrete IL-4, others
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demonstrate that Fyn-deficient T cells are skewed toward a Th2 phenotype,
results in increased IL-4 production and decreased IFNγ250,251,254,263. These
cytokines promote the production of different Ig isotypes. While IL-4 promotes
IgG1 and IgE class switching, IFNγ induces IgG2a production40-42,80.Here we
demonstrate that Fyn-KO mice have dramatically reduced basal and antigenspecific IgG2a levels. These results are consistent with the notion that IFNγ
production is impaired in Fyn-KO mice.
We also noted that Fyn-KO mice have a delayed kinetics in the production
of antigen-specific IgG1 and IgG2b. Moreover, these mice had fewer numbers of
GC B cells following immunization. IL-4 has been implicated in GC formation.
Indeed, IL-4-deficient mice have smaller GCs than WT mice264.Given the fact that
Fyn is important for IL-4 production, it is possible that reduced IL-4 leads to fewer
GC B cells resulting in impaired Ig kinetics.
Along with defective GC formation, we noticed a decrease in splenic PCs
and TFH cells. It is likely that they are both secondary to the decrease in GC B
cells. Previous work demonstrated that SAP-Fyn interactions were dispensable
for TFH development, as TFH cells developed normally in SAPR78A mice249.
Therefore, our results suggest that Fyn regulated TFH differentiation in a SAPindependent manner.
Given that Fyn is involved cytokine production, it is hard to delineate
whether the defects in immunoglobulin production observed result from B cell
intrinsic defects or if they are due to altered cytokine production. However, the
fact that Fyn-deficient B cells had impaired antibody production in vitro indicates
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that Fyn plays a role in B cell activation. Interestingly, Fyn-deficient B cells
proliferated normally, suggesting a role for Fyn in antibody class switching.
Future studies will be needed to identify the mechanism underlying the
defects in humoral responses in Fyn-deficient mice. While our in vitro studies
demonstrate a B cell intrinsic defect, we have not demonstrated a B cell defect in
vivo. In order to identify whether the phenotype observed results from Fyndeficiency in B cells or T cells, mice that lack lymphocytes (RAG2-/- mice) will be
reconstituted with a combination of WT B cells and Fyn-deficient T cells or vice
versa. These mice will then be immunized and antibody responses will be
assessed. It is likely that both B cell and T cell-expressed Fyn play a role in
humoral responses.
Fyn-deficient mice have been studied extensively. It has been
demonstrated that Fyn kinase is required for NKT cell development245. Moreover,
it has been demonstrated that Fyn is also involved in T cell activation and
cytokine production143,242,254. Moreover, some studies have demonstrated that
Fyn is important for antibody production in vivo, although others failed to identify
such role252,254,265. Our results further extend our knowledge of Fyn’s role in
lymphocyte biology. Here we demonstrate that Fyn is important for optimal
humoral responses by regulating GC formation and possibly CSR. Moreover, our
data show that Fyn mediates antibody production via B cell intrinsic and extrinsic
manners.
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